Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Step | Module/Script | Run |
---|---|---|
Status | Level | Outcome | Output files (excluding log files) |
---|---|---|---|
Reference reformatting/validation
custom script
If custom reference is provided
Read QC
trimmomatic
Always
Primer trimming (on FASTQ)
trimmomatic
If primer set exists
Read dehosting
human_read_scrubber
If checked in Input Form
Assembly
MEGAHIT
If reference FASTA and BED files imply more than one genome as reference
Contig clustering
CD-HIT
If assembly ran
Reference selection
custom script
If assembly ran, otherwise input reference database is used as is
Primer alignment / reformatting
custom script
If primer set is provided. Primers are aligned to selected reference sequences if coordinates are not provided. Otherwise, primers mapping to selected reference sequences (based on the provided primer coordinates) are selected as final set of primers
Map/Align
DRAGEN
If at least one reference sequence is generated
Post-facto primer trimming (on BAM)
custom script
If Map/Align ran and primer set exists
Sample filtering based on amplicon coverage
custom script
If Map/Align ran and primer set exists
Variant calling
DRAGEN
If Map/Align ran and sample passed filter above
Consensus sequence generation
custom script
If Map/Align ran and sample passed filter above
Pipeline completed
Pipeline
Pipeline exits
All
Custom files are not formatted correctly
Pipeline
Pipeline exits
None
None of the primers provided in custom primer definition file align to selected reference sequences
Sample
Skip post-factor primer trimming and sample filtering based on amplicon coverage for this sample
All except for amplicon-related output files
No reference found after assembly
Sample
Do not proceed to short read map alignment for this sample
Contig FASTA
Insufficient amplicon coverage
Sample
Do not proceed to variant calling for this sample
Contig FASTA (if assembly was run)
Launch the DRAGEN Microbial Amplicon BaseSpace application.
Choose the analysis name and destination project to save results to.
Choose either Biosample or Project as input method. Selecting Project will result in all biosamples in the selected project being analyzed.
Choose the appropriate Amplicon Primer Set that matches the primer design used to prepare your samples or choose Custom to provide your own. See this page to learn more about the custom option.
If needed, uncheck the appropriate boxes to disable Pangolin and Nextclade analyses. These tools perform phylogenetic analysis and lineage assignment for SARS-CoV-2 (Pangolin) and other viruses (Nextclade). Depending on the chosen Amplicon Primer Set, these tools may not be applicable.
If needed, expand the Advanced Workflow Settings box to change default settings. Click on the "i" circle next to each setting for more information.
If needed, expand the Additional DRAGEN Command Line Arguments to provide additional arguments to default DRAGEN commands.
Click “Launch Application"
This page provides an overview of the software available on Illumina's cloud platforms
Infectious Disease and Microbiology software include powerful bioinformatics tools to analyze NGS data ranging from single microbial genomes to complex microbial communities of thousands of viruses, bacteria, parasites, and fungi. This comprehensive secondary analysis suite of tools supports target specific workflows such as amplicon and hybrid capture enrichment sequencing, to generalized microbiology methods like small WGS, shotgun sequencing, or 16S Amplicon. All tools are available on BaseSpace, with some available on On-board select Illumina Sequencers.
Click the links below to learn more about our currently-available infectious disease software products:
A BED-like tab-separated value (TSV) file with no header row and with 4 or 5 columns:
accession
: each sequence accession as it appears in Custom Reference FASTA heaer
start
: start position (always set to 0)
end
: end position (sequence length)
genome
: full name of the virus the sequence belongs to (e.g. Influenza A H1N1)
(optional) segment
: how this sequence is labeled within the virus (e.g. Segment 4 (HA)). Set to 'Full' if the sequence is the full genome
This file affects how sequences are labeled in the output.
Sequence names must match those in Custom Reference FASTA. The same set of sequences must appear in both.
If there are multiple viruses, their names should be unique. For example, if there are multiple Influenza genomes, they should not be labeled with the same virus name in the 4th column.
If the Custom Reference FASTA includes sequences from multiple segments, it is strongly recommended to provide this BED file. Otherwise, each segment will be treated independently and not all of them may be used as reference.
Provide a BED file with at least 4 columns: accession
, start
, end
, primerName
. Additional columns can be included: pool
, strand
, sequence
, but their order must be maintained.
For example, accession
, start
, end
, primerName
, pool
for 5-column BED format:
And accession
, start
, end
, primerName
, pool
, strand
, sequence
for 7-column BED format:
Option 1. One line per amplicon with 3 columns: ampliconName
, forwardSequence
,reverseSequence
.
Option 2. One line per primer with 3 columns: primerName
, sequence
, pool
.
General
All text is case sensitive.
Any line starting with '#' is ignored. This can be used to add a header line with column names.
Every line must have the same number of columns and format (except those starting with '#').
Any number of spaces can separate the columns. A value within a single column should not have any space.
BED format
Per standard BED conventions, sequence coordinates are given as 0-based, half-open intervals, such that the start
field (2nd column) contains the first nucleotide in the primer binding site and the last nucleotide in the primer binding site is the value in the end
field (3rd column) minus 1.
accession
field must contain a sequence identifier that matches the header of the FASTA file containing the sequence that the coordinates are relative to.
Multiple sequence identifiers (accession
) are permitted within one file.
Primer name
primerName
must be unique and encode the name of the amplicon for which the primer is designed, the direction tag indicating which side of the amplicon, left or right, the primer belongs to, and an optional indicator that the primer is an alternative primer for that amplicon.
In addition to _LEFT
and _RIGHT
, we permit _L
and _R
as direction tags in primerName
. Any text after the direction tag should be separated by an underscore.
Text in primerName
before the direction tag is considered to be an amplicon identifier. Ensure that the text of the amplicon identifier is unique for that amplicon and that the direction tag occurs only once in primerName
.
Each amplicon must have at least one left and right primer (including alternative primers) associated with it.
Alternative primers are used to bind to locations that avoid sequence variation in the default primer binding site that may disrupt hybridization. An amplicon may have an arbitrary number of alternative primers (as long as the primer name is unique), but most amplicons will have none. Alternative primers are indicated by the presence of the _alt
after the direction tag in primerName
, followed by optional text to distinguish between different alternative primers, such as a number.
Examples of valid primer names:
MY_SEQUENCE_434_A_LEFT
virus1_L
amplicon_4934m_RIGHT_alt
amplicon_4934m_RIGHT_alt1
amplicon_4934m_R_altprimerB
Examples of invalid primer names:
LEFT_MY_SEQUENCE_434_A
virus1_l
amplicon_4934m_RIGHT_L
Note: Some files may not be generated depending on user inputs and pipeline outcome
Analysis_Results/<analysisId>.report.html
displays tables and plots that summarize results from all samples combined.
An output directory named after each sample contains <sampleName>.html
, which displays tables and plots specific to the sample. The HTML files are identical to the ones displayed in BaseSpace Reports.
Each sample directory also contains the following subdirectories and output files:
<sampleName>.amplicon_coverage.log | Log from computing coverage metrics for each amplicon in a sample |
---|---|
<sampleName>.hard_masked_consensus.fa | FASTA containing all hard-masked consensus sequences generated for a sample |
---|---|
Once the analysis completes, the "REPORTS" tab on BaseSpace enables users to view the Summary of the entire analysis, which summarizes results from all input samples, as well as individual Sample Report for each sample.
In addition to the built-in options, DRAGEN Microbial Amplicon supports the use of custom reference genomes and primer definitions. These files must be uploaded to a BaseSpace Project before they can be used. See https://help.basespace.illumina.com/manage-data/import-data for more information about importing files into BaseSpace.
In the app input form, select the 'Custom' option for 'Amplicon Primer Set'. Then expand the 'Custom Reference' settings to provide the following:
Custom Reference FASTA for Consensus Generation (required)
Custom Reference BED (optional)
Custom PCR Primer Definitions (optional)
If the 'Custom' option is selected for 'Amplicon Primer Set', the user must provide a custom FASTA file containing one or more reference sequences as the target for read alignment (and as the basis for generating consensus sequences). The software generates the required DRAGEN hash tables and other auxiliary files automatically, so there is no need to process the FASTA file with a separate app. Note that not all provided reference sequences in the FASTA file may be used for read alignment and consensus sequence generation.
Optionally, a reference BED file may be provided to add information about each reference sequence in the FASTA file, such as human-readable names to be used in the reports. For multi-segment genomes such as Influenza, this file assigns the segment name to each sequence, which allows the software to group individual segment sequences by genome. See the following page on the format of this file:
Optionally, a TSV file may be provided to define the primer sequences or binding locations, which are used for two purposes:
Primer sequences are trimmed from reads, which eliminates sequences that may come from the primer sequences themselves (which we do not want) from sequences contributed by the biological sample (which we do want). This reduces reference bias that can incorrectly lower the observed allele frequency of true sequence variants in primer binding sites.
Primer locations are used to define the amplicons expected from PCR reactions. The read coverage within the unique (non-overlapping) amplicon regions is used to determine whether each amplicon is reliably detected. The percentage of detected amplicons is used to determine whether sufficient material exists to accurately call variants and generate consensus sequences from the sample.
See the following pages for further information:
Optionally, one or more Nextclade datasets can be selected to use for phylogenetic analysis of the consensus sequences generated from the samples. Every selected dataset will be applied to every consensus sequence generated in every sample.
DRAGEN Microbial Amplicon is a software application designed to analyze sequencing data from amplicon library preps (both DNA and RNA) on microbiological samples, with an emphasis on viruses. Illumina sequencing reads are processed to generate consensus sequences that represent a best estimate of the population of viral sequences in each sample. Where appropriate, these consensus sequences are further analyzed by the phylogenetic analysis tools Nextclade and/or Pangolin to provide an identification of the clade or lineage of each sequence.
Data can be provided in one of the following ways:
Samples / biosamples with FASTQ datasets (see details in library preparation documents)
A project containing one or more samples / biosamples with FASTQ datasets
All samples / biosamples in the selected project will be analyzed
Supported amplicon primer schemes
Chikungunya
Illumina
Dengue
Serotype 1 - Illumina
All serotypes -
Influenza / - Universal
Mpox
Pan-clade -
Clade I - Illumina
Clade II -
RSV
SARS-CoV-2 - ARTIC
Zika -
Custom genome and primer sets
Users can upload custom files to provide user-defined reference genome set and primer definitions. Multiplexed amplicon panels targeting multiple organisms in the same reaction are supported.
Align reads to the default reference genome or selected reference genomes using DRAGEN v4.3.6
Trim primer sequences in aligned reads based on coordinates
Filter out samples with insufficient amplicon coverage
Call sequence variants from the alignments using DRAGEN Somatic v4.3.6 and apply them to the corresponding reference genomes to create consensus sequences
If applicable, run Nextclade/Pangolin on the consensus sequences
Consensus sequences representing a best estimate of targeted sequences
Tables and plots reporting read counts, coverage, and Nextclade/Pangolin results
BaseSpace Sequence Hub
The sequences are labeled according to the best match in the reference database, which is not exhaustive and the labels should not be taken as definitive for strain-typing. If strain typing is needed, the built-in Nextclade and/or Pangolin tools can be used for supported organisms. Alternatively, a BLAST or similar search of nucleotide databases may provide a more detailed match.
Because of sequence homology, it is possible that organisms with very few reads will result in the generation of a sequence not present (false positive). Although the de novo assembly step of this software largely mitigates such instances, sequences with very low horizontal coverage (< 5%) should be treated with caution.
<sampleName>.sample_contig.fasta | FASTA containing all contig sequences generated for a sample |
---|---|
<sampleName>.coverage.tsv | TSV reporting base-pair resolution coverage values across all reference sequences used in short read alignment |
---|---|
<sampleName>_<datasetName>.aligned.fasta | FASTA generated by Nextclade from aligning consensus sequences to a reference sequence |
---|---|
<sampleName>-replay.json | JSON reporting parameters and versions used when running DRAGEN to perform variant calling |
---|---|
Status | Level | Outcome |
---|---|---|
Trim and filter reads using
Remove off-target reads using DRAGEN v4.3.6 kmer classifier (for custom reference, remove human reads using a modified version of the v2.2.1)
For organisms with one default reference genome, skip this step. For organisms with multiple candidates, trim primer sequences in reads using , perform assembly using , cluster contigs using , map contigs to candidate reference genomes using , then select reference genomes based on the mapping
<sampleName>.amplicon_coverage.csv
CSV reporting coverage metrics for each amplicon in a sample
<sampleName>.amplicon_detection.json
JSON reporting amplicon detection results for a sample
<sampleName>.soft_masked_consensus.fa
FASTA containing all soft-masked consensus sequences generated for a sample
<sampleName>.sample_consensus.fasta
<sampleName>.hard_masked_consensus.fa but with informative headers
<sampleName>_<genomeName>.genome_consensus.fasta
<sampleName>.sample_consensus.fasta but specific to consensus sequences generated using reference sequences that belong a particular genome
<sampleName>_<accessionName>.accession_consensus.fasta
<sampleName>.sample_consensus.fasta but specific to consensus sequences generated using a particular reference sequence
<sampleName>.consensus.json
JSON containing information on all consensus sequences generated for a sample
<sampleName>_<genomeName>.genome_contig.fasta
<sampleName>.sample_contig.fasta but specific to contigs mapping to reference sequences that belong a particular genome
<sampleName>_<accessionName>.accession_contig.fasta
<sampleName>.sample_contig.fasta but specific to contigs mapping to a particular reference sequence
<sampleName>.contig.json
JSON containing information on all contig sequences generated for a sample
<sampleName>-replay.json
JSON reporting parameters and versions used when running DRAGEN to perform short read alignment
<sampleName>-unmapped_ S1_L001_R1_001.fastq.gz
FASTQ containing R1 reads that did not map to any selected reference sequences
<sampleName>-unmapped_ S1_L001_R2_001.fastq.gz
FASTQ containing R2 reads that did not map to any selected reference sequences
<sampleName>-unmapped-singleton_S1_L001_R1_001.fastq.gz
FASTQ containing singleton reads that did not map to any selected reference sequences
<sampleName>.bam
BAM containing all short read alignments
<sampleName>.bam.bai
BAI for <sampleName>.bam
<sampleName>.mapping_metrics.csv
CSV generated by DRAGEN to report mapping metrics
<sampleName>.trim.log
Log from performing post-facto primer trimming after short read alignment
<sampleName>.trimmer_metrics.csv
CSV generated by DRAGEN to report trimmer metrics
dragen_run_<runId>.log
Log from running DRAGEN to perform short read alignment
<sampleName>.report.json
JSON containing summary metrics generated for a sample
<sampleName>_<datasetName>.auspice.json
Auspice JSON generated by Nextclade containing output phylogenetic tree
<sampleName>_<datasetName>.csv
CSV generated by Nextclade to report results from mutation calling, clade assignment, quality control, etc.
<sampleName>_<datasetName>.json
<sampleName>_<datasetName>.csv in JSON format
<sampleName>_<datasetName>.ndjson
<sampleName>_<datasetName>.csv in NDJSON format
<sampleName>_<datasetName>.tsv
<sampleName>_<datasetName>.csv in TSV format
<sampleName>.consensus_filtered.bcftools_stats.txt
TXT generated by BCFtools stats command to report statistics on called variants that passed the consensus filter
<sampleName>.consensus_filtered.summary.csv
CSV generated by BCFtools query command to summarize called variants that passed the consensus filter
<sampleName>.consensus_filtered.vcf.gz
VCF containing called variants that passed the consensus filter
<sampleName>.consensus_filtered.vcf.gz.tbi
TBI for <sampleName>.consensus_filtered.vcf.gz
<sampleName>.hard-filtered.bcftools_stats.txt
TXT generated by BCFtools stats command to report statistics on called variants
<sampleName>.hard-filtered.summary.csv
CSV generated by BCFtools query command to summarize called variants
<sampleName>.hard-filtered.vcf.gz
VCF containing called variants
<sampleName>.hard-filtered.vcf.gz.tbi
TBI for <sampleName>.hard-filtered.vcf.gz
<sampleName>.vc_metrics.csv
CSV generated by DRAGEN to report variant calling metrics
dragen_run_<runId>.log
Log from running DRAGEN to perform variant calling
Completed successfully
Pipeline
Exit with all applicable output files
Custom files are not formatted correctly
Pipeline
Exit early with error
No remaining reads after preprocessing
Sample
Exit early with a report of read counts
No contig generated
Sample
Exit early with a report of read counts
No reference found after assembly
Sample
Exit early with a report of read counts and contig FASTA
None of the primers provided in custom primer definition file align to selected reference sequences
Sample
Skip post-factor primer trimming and sample filtering based on amplicon coverage for this sample
Insufficient amplicon coverage
Sample
Exit early before variant calling and consensus sequence generation
Amplicon sequencing, especially of RNA viruses, requires additional bioinformatics processing to ensure maximum quality of the resulting data.
In RT-PCR, a reverse transcriptase enzyme first generates cDNA molecules using the RNA molecules in the sample as templates, before amplifying the cDNA sequences using a DNA polymerase enzyme during PCR. These amplified cDNA sequences are then further processed to generate the sequencing libraries. Both of these enzymes can potentially introduce an incorrect base into a sequence, generating a position where the resulting sequence does not match the sequence in the sample -- that is, an error.
Reverse transcriptases exhibit error rates that are multiple orders of magnitude higher than those of DNA polymerases.
When large numbers of nucleic acid molecules are present in a reaction, these individual misincorporation errors are largely uncorrelated and appear at very low frequencies, so that they are typically ignored by variant callers.
However, when there is a small number of incoming nucleic acid molecules, such as for a low-titer sample, an error that occurs during the RT step or early in the PCR reaction can, as a result of sampling noise, be amplified to high frequencies in the resulting sequencing libraries. The variant caller may treat this error as a sequence variant, since it is a true sequence variant in the context of the library provided to the instrument. As a result, these artifactual sequence variants often have high allele frequency and quality scores, which makes them very difficult to detect, and appear in the final consensus sequence. While less common, it is also possible for a true sequence variant to have its allele frequency depressed by this same process (if the error results in a reversion to the reference sequence).
Since it is difficult to identify enzyme-introduced false variants after the fact, we instead take a preemptive approach of determining if there is sufficient sample material present before variant calling and consensus sequence generation in order to ensure data quality.
Specifically, the app calculates the number of amplicons with at least 1x coverage for at least 90% of the non-overlapping portion of the amplicon sequence. The 1x coverage threshold used here is fixed and independent of the minimum read coverage depth for consensus sequence generation which defaults to 10x. The number of amplicons that meet this threshold is then divided by the total number of amplicons expected in the experiment, which is the number of amplicons whose location falls in reference sequences selected for short read alignment. If the resulting percentage is at least 80%, the sample is considered to have sufficient material for accurate variant calling. If it is below this threshold, the sample is not processed further to avoid spurious variant calls. The user can override the 80% threshold in the "Minimum percentage of amplicons with at least 90% coverage ≥ 1x to enable variant calling and consensus sequence generation" control in the "Advanced Workflow Settings" section.
The threshold above was determined through data analysis using an experimentally-determined threshold corresponding to minimum concentration needed to produce reliable variant calls. We assumed that higher nucleic acid concentrations leads to a higher probability of amplifying each amplicon.
Launch the DRAGEN Targeted Microbial BaseSpace application.
After choosing a name and destination project for the Analysis, choose either “Biosample” or “Project” as input type. Selecting “Project” will result in all biosamples in the selected project being analyzed.
Next, choose between Enrichment and Amplicon for Experiment Type. Libraries prepared with IMAP should be run as “Amplicon” experiments. Choose the appropriate Amplicon Primer Set that matches the primer design used to prepare your samples or choose “Custom” to provide your own genome references and primer designs. Note that all provided files must first be uploaded to a BaseSpace project before they can be selected in the software.
To use a custom reference and primer design, click the “Custom Reference” block to expand it.
At a minimum, the user must provide a custom genome reference containing one or more target sequences (to be used for alignment, variant calling and consensus generation) in the form of a FASTA file.
Optionally, the user may provide a BED file that assigns human-readable names and segment numbers (if applicable) to each sequence in the provided FASTA file. Note that the accessions in the genome definition file must match the first part (before whitespace) of the FASTA headers. See the pages for “Genome Definition File Format Specification” in the “Supporting Information” section of this user guide for information on the required format of this file.
Optionally, the user may provide a file containing the locations or sequences of the primers used to prepare this sample. These primer definitions are important to guide the trimming of primer sequence from reads that overlap the binding sites, as well as to define the boundaries of the amplicons whose coverage is used to determine if the sample has sufficient viral material to reliably call variants and generate consensus sequence.
Optionally, the user may choose one or more NextClade datasets to use for phylogenetic analysis of the consensus sequences generated from the samples.
Check the appropriate boxes to enable or disable Pangolin and/or NextClade analysis if desired. These tools perform phylogenetic analysis and lineage assignment for SARS-CoV-2 (Pangolin) and other viruses (NextClade). Depending on the chosen Amplicon primer set, not all of these options may be applicable.
Click “Launch Application” to begin the Analysis.
A: For many sample types, especially clinical, wastewater, or environmental samples, viral RNA or DNA makes up a tiny proportion of the total nucleic acids, with the remainder dominated by host or bacteria/archaea. Therefore, even with a dramatic increase of abundance over what you would obtain without targeted sequencing, the percentage of targeted reads can still be low.
A: The 10x threshold is applied per-nucleotide. Any positions below 10x coverage will be hard-masked with "N".
A: This message is to warn users that the sequence accession in the consensus genome does not necessarily reflect the true phylogeny of the organisms in the sample and should not be taken as such.
Because the app uses a limited set of reference sequences, the accession in the consensus sequence FASTA file headers (and coverage plots, etc) merely reflects the best match from that limited set. There may be sequences in RefSeq or elsewhere that are a closer match.
A: The denominator in the "Detected Amplicons" columns is based on the reference sequences selected based on de novo assembled contigs. Depending on the quality of the sample and/or reads, the assembler may not have enough data to generate a contig for some segments. Shorter segments are more likely to be missed. If only 7 segments are selected as reference for short read alignment, then we expect 7 amplicons in total. If you believe that the sample should contain all 8 segments, you can download the contig FASTA file from our report page and submit it to NCBI BLAST to see if all 8 segments are present in the contig sequences.
One known issue is that chimeric reads can be generated during library preparation, which can lead to chimeric contigs, where the contig sequence contains sequences from more than one segment. This can result in missing an entire segment in the reference selection stage. A workaround may be to filter out chimeric reads from your FASTQ files before running the app.
Alternatively, you can force the app to use all 8 segments of a particular Influenza genome by providing a custom reference FASTA file with all 8 segment sequences and a custom reference BED file with the genome
column to set to the same value (e.g. Influenza A). This way, the app skips assembly and uses all 8 segments as the reference sequences for short read alignment.
A: The "Detected Amplicons" column shows the number of detected amplicons over the total number of expected amplicons. The percentage of detected amplicons is used to infer if the sample is of sufficient quality for variant calling. The "% callable bases" column shows the percentage of the selected reference genome whose bases are at or above the minimum read coverage depth for consensus sequence generation, which is computed independent of amplicons.
Both metrics are useful to assess the quality of the sample, but the percentage of detected amplicons is used by the app after short read alignment to filter out low-titer samples and the percentage of callable bases is not.
A: Not necessarily. Your virus of interest may be present in the sample, but the app may not have generated a consensus sequence for it for various reasons.
One reason could be that there are too few reads coming from that virus. Tools like DRAGEN Metagenomics can be used to characterize what is in the sample more broadly.
Another reason could be that the virus in your sample is too divergent from the reference sequences used in the app. In such cases, we recommend downloading the contig FASTA file (if available) from our report page and submitting it to NCBI BLAST. If you do see a genome that matches your virus of interest, you can provide that to the app as a custom reference genome.
A: De novo assembly is performed only if there are multiple candidate reference genomes, which is typically when there are multiple serotypes, strains, subtypes, or clades. This currently applies to the following Amplicon Primer Set options:
Dengue Virus All Serotypes, 400-bp DengueSeq primers
Influenza A, Universal primers
Influenza B, Universal primers
Influenza A and B, Universal primers
Mpox All Clades, 2500-bp ARTIC-INRB v1 primers
Respiratory Syncytial Virus (RSV), CDC primers
Respiratory Syncytial Virus (RSV), WCCRRI primers
If a custom reference FASTA file is provided, assembly is performed if there are multiple sequences in the file. If a custom reference BED fils is also provided, assembly is performed if based on the BED file there are multiple genome-segment pairs (or multiple non-segmented full genomes). Otherwise, all sequences in the custom reference FASTA file are used as reference for short read alignment.
A: In most cases, the consensus sequence FASTA file. Contig sequences are useful if the reference sequences used for consensus sequence generation were not the best match. They should be used with caution however because there is no filtering of base calls based on coverage or quality as done in consensus sequence generation.
A: It is most likely that the custom database was not formatted correctly. Below are requirements for the Custom Reference FASTA For Consensus Generation:
Do not use Spaces in the file name, instead use an underscore "_"
Do not exceed 25 characters in the file name
File extension must be .fasta or .fa
Do not exceed the file size limitation: 16GB for a single file or 25GB for multiple files
Do not have duplicate entries
If providing a Custom Reference BED and/or Custom PCR Primer Definitions in BED format, the names in the first column of the BED file (accession
) must match the names that appear in the FASTA (text after >
and before the first whitespace character).
Please see this page on general guidelines to upload data to BaseSpace for more details. If you continue having issues, reach out to techsupport@illumina.com.
QC
trimmomatic
Always
Primer trimming (on FASTQ)
trimmomatic
If assembly is to run
Remove off-target reads
DRAGEN
If checked in Input Form
Assembly
MEGAHIT
If reference FASTA and BED files imply more than one genome as reference
Contig clustering
CD-HIT
If assembly ran
Reference selection
custom script
If assembly ran, otherwise input reference database is used as is
Map/Align
DRAGEN
If at least one reference sequence is generated
Post-facto primer trimming (on BAM)
custom script
If Map/Align ran and primer set exists
Sample filtering based on amplicon coverage
custom script
If Map/Align ran and primer set exists
Variant calling
DRAGEN
If Map/Align ran and sample passed filter above
Consensus sequence generation
custom script
If Map/Align ran and sample passed filter above
The Sample Report contains at most four tabs: Sample QC, Virus Metrics, Nextclade Report, and Pangolin Report.
This tab contains tables and plots summarizing the sample.
This table reports summary metrics for the sample, such as Status and Detected Amplicons. See here for their definitions.
This plot displays counts of reads that fall into different categories. See here for their definitions.
This plot displays the number of reads that mapped to each reference sequence. If there is a single reference sequence (e.g. SARS-CoV-2), one bar is shown.
This table provides the number of reads that mapped to each reference sequence along with the genome and segment names of the reference sequence. The "Download CSV" button enables downloading the contents of the table as a text comma-separated value (CSV) file.
This table summarizes results for each viral genome generated in the sample with each row corresponding to a single viral genome. For segmented viruses like Influenza, a row will summarize information across multiple sequences generated for a single viral genome.
At the top is the "Download CSV" button, which enables downloading the contents of the table as a text comma-separated value (CSV) file.
The table itself contains rows for every viral genome with at least one sequence generated in the sample with the following columns:
Virus: Name of the viral genome
For custom references, this will be the part of the FASTA header before the first whitespace character for the corresponding reference sequence if no custom genome definition file is provided. If a custom genome definition file is provided, this will be the value of the genomeName
column
% Callable: Percentage of bases in the reference sequence with coverage above the minimum read coverage depth for consensus sequence generation (10x by default). This is computed across all sequences belonging to the viral genome. See here for more information.
Median Coverage: Median coverage value (in number of reads overlapping each position) over the entire reference genome (not just the generated consensus sequence).
This table summarizes the results for each sequence generated in the sample. For segmented viruses like Influenza, there are typically multiple rows with the same virus name. Otherwise, this table contains similar information as the Metrics By Virus table.
At the top is the "Download CSV" button, which enables downloading the contents of the table as a text comma-separated value (CSV) file.
Virus: Name of the virus genome
Segment: Name of the segment to which the reference sequence corresponds. For non-segmented viruses, this is typically set to "Full".
Accession: Unique identifier of the reference sequence (text before first space in FASTA header if custom reference FASTA was provided)
% Callable: Percentage of bases in the reference sequence with coverage above the minimum read coverage depth for consensus sequence generation (10x by default). See here for more information on this metric.
Callable Bases: Number of bases in the reference sequence with coverage above the minimum read coverage depth for consensus sequence generation (10x by default)
Median Coverage: Median coverage value (in number of reads overlapping each position) over the entire reference genome (not just the generated consensus sequence).
Consensus Length: Length of the final consensus, without leading and trailing masked bases if sequence trimming is enabled. Sequence trimming can be disabled in the Input Form under Advanced Workflow Settings.
Displays a trace of read coverage over each reference genome. On the top right is a drop-down menu that allows users to switch between genomes. The blue line represents the read coverage, with the coverage depth in log 10 of number of reads on the y-axis and the genomic position in the reference genome on the x-axis.
For segmented viruses like Influenza, coverage values for each segment is displayed in a horizontally stacked fashion. Grey blocks at the top show their boundaries.
This tab contains tables reporting the results of the Nextclade analysis performed on the generated consensus sequences in the sample. See here for more details.
This tab contains tables reporting the results of the Pangolin analysis performed on the generated consensus sequences in this sample. See here for more details.
DRAGEN Targeted Microbial is a software application designed to analyze sequencing data from enrichment and amplicon library preps (both DNA and RNA) on microbiological samples, with an emphasis on viruses. Illumina sequencing reads are processed to remove human-origin sequence, then assembled into consensus sequences that represent a best estimate of the population of viral sequences in each sample. Where appropriate, these consensus sequences are further analyzed by the phylogenetic analysis tools NextClade and/or Pangolin to provide an identification of the clade or lineage of each sequence.
Samples / biosamples with FASTQ datasets (see details in library preparation documents)
A project containing one or more samples / biosamples with FASTQ datasets
all samples / biosamples in the selected project will be analyzed
Supported hybrid-capture enrichment panels
Supported amplicon primer schemes
Chikungunya (Grubaugh lab; Illumina)
Dengue Serotype 1 (Grubaugh Lab; Illumina)
MPXV (Grubaugh Lab)
SARS-CoV-2 (ARTIC v3, v4, v4.1, v5.3.2)
Zika (Grubaugh lab)
Custom genomes and panels
Supports uploading FASTA files to use as reference genomes for both enrichment and amplicon panels, as well as custom primer definitions for amplicon panels. Multiplexed amplicon panels targeting multiple organisms in the same reaction are supported.
Reads are trimmed and filtered using Trimmomatic with the following parameters: LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36
.
Human reads are removed with a modified version of the SRA Human Read Scrubber tool.
MEGAHIT is used to perform de novo assembly on the scrubbed reads.
CD-HIT-EST is used to cluster similar contigs to reduce redundancy.
The resulting contigs are mapped to a set of reference genomes using minimap2.
The best matching reference for each contig is selected for short read mapping.
The scrubbed reads from step 2 are aligned to the selected reference genomes using DRAGEN v4.2.4
Sequence variants are called from the alignments using DRAGEN Somatic Small Variant Caller v4.2.4 and applied to the corresponding reference sequences to create consensus sequences.
If applicable, Pangolin and/or Nextclade are run on the consensus sequences.
The software generates consensus sequences representing a best estimate of the population of targeted sequences in the sample. NextClade and Pangolin analysis are run on select organisms. See this page for details:
The sequences are labeled according to the best match in the panel references. These references are not exhaustive and the labels should not be taken as definitive for strain-typing. If strain typing is needed, the built-in NextClade and/or Pangolin tools can be used for supported organisms. Alternatively, a BLAST or similar search of nucleotide databases may provide a more detailed match.
Because of sequence homology, it is possible that organisms with very few reads will result in the generation of a sequence not present (false positive). Although the de novo assembly step of this software largely mitigates such instances, sequences with very low horizontal coverage (< 5%) should be treated with caution and are highlighted as "low confidence" in the reports.
BaseSpace Sequence Hub (native BaseSpace app)
The Summary contains at most three tabs: Summary Report, Nextclade Report, and Pangolin Report.
This table provides a top-line summary of each of the analyzed samples.
At the top is the "Download CSV" button, which enables downloading the contents of the table as a text comma-separated value (CSV) file.
Next is the table itself, which contains one row per sample and the following columns:
Sample: Name of the BaseSpace sample analyzed
Status: Status of the sample analysis
Input Reads: Total number of reads in input FASTQs
Mapped Reads: Number of reads that map to reference sequences during short read alignment
Detected Amplicons: Proportion of amplicons detected out of the total expected for the sample, which is used to to determine if the sample is sufficient quality for variant calling. See this page for more details.
Num Genomes: Number of genomes chosen during the reference selection stage
Virus: Name of the genome to which the reference sequence belongs
% Callable: Percentage of bases in the reference sequence with coverage above the minimum read coverage depth for consensus sequence generation (10x by default)
Callable bases are those for which reliable variant calling can be performed and therefore for which the software can output a base call. They are defined as genomic positions with read coverage above the minimum read coverage depth for consensus sequence generation (10x by default).
When generating consensus sequences, genomic positions below the threshold are hard-masked with "N" characters to avoid reference bias (inclusion of a reference base when the true base cannot be accurately determined).
This percentage is calculated over the lengths of the reference genome(s), not the final consensus sequence(s) which may be trimmed.
This stacked bar plot contains counts of reads that fall into the following categories:
Removed in Downsampling: Reads that were removed during downsampling because the user specified a downsampling target in the Input Form under Advanced Workflow Settings
Removed in QC: Reads removed as poor quality reads based on quality thresholds during pre-processing
Removed as Duplicate: Reads that were labeled as duplicate during short read alignment. Removal of them can be disabled in the Input Form under Advanced Workflow Settings
Removed in Trimming: Reads that were removed in the initial sequence-based primer trimming step and were excluded from further processing
Removed in De-hosting: Reads that were filtered out as human reads based on kmer-based classification during pre-processing.
This improves the quality of downstream analysis and helps ensure that human sequences are not included in the output BAM files.
This is applied only if 'Amplicon Primer Set' was set to 'Custom' in the Input Form.
This can be disabled in the Input Form under Advanced Workflow Settings by unchecking "Remove off-target reads".
Removed as Off-target: Reads that were filtered out as off-target reads based on kmer-based classification during pre-processing
Similar de-hosting, this improves the quality of downstream analysis.
Off-target is defined as not coming from the target organism, which is determined based on the 'Amplicon Primer Set' selection in the Input Form. For example, if "Influenza A and B, Universal Primers" option is selected, a kmer database generated from a large collection of publicly available Influenza sequences is used to separate reads likely coming from Influenza from the rest.
This can be disabled in the Input Form under Advanced Workflow Settings by unchecking "Remove off-target reads".
Unmapped: Reads that were not aligned to any reference genomes
Mapped. Reads that were mapped to at least one reference genome
This tab contains tables reporting the results of the Nextclade analysis performed on the generated consensus sequences across all samples. Nextclade is run if the "Enable NextClade" box is checked on the Input Form and one of the following is true:
'Amplicon Primer Set' is set to a non-custom set with a reference with Nextclade dataset available and a valid consensus sequence was generated.
'Amplicon Primer Set' is set to 'Custom' and one or more Nextclade datasets are selected under 'Custom Reference'. In this case, each of the selected Nextclade datasets is applied to each consensus sequence generated for every sample. This may result in multiple Nextclade results for each consensus sequence.
Each table contains a "Download CSV" button which allows the user to download the contents of the report as a text CSV file.
All content shown in the tab is derived from the output of the Nextclade software. Please see the Nextclade documentation for more details.
This tab contains tables reporting the results of the Pangolin analysis performed on the generated consensus sequences across all samples. Pangolin is run if the "Enable Pangolin" box is checked on the input form and one of the following is true:
'Amplicon Primer Set' is set to a non-custom set with SARS-CoV-2 as reference (e.g. SARS-CoV-2, ARTIC v5.4.2 primers) and a valid consensus sequence was generated
'Amplicon Primer Set' is set to 'Custom'. In this case, Pangolin is applied to every consensus sequence generated for the sample since the software assumes all of them to be potentially SARS-CoV-2 sequences.
Each table contains a "Download CSV" button which allows the user to download the contents of the report as a text CSV file.
All content shown in the tab is derived from the output of the Pangolin software. Please see the Pangolin documentation for more details.
Provide a BED file with at least 4 columns: chrom
, chromStart
, chromEnd
, primerName
. Additional columns can be included: pool
, strand
, sequence
, but their order must be maintained.
For example, chrom
, chromStart
, chromEnd
, primerName
, pool
for 5-column BED format:
And chrom
, chromStart
, chromEnd
, primerName
, pool
, strand
, sequence
for 7-column BED format:
Option 1. One line per amplicon with 3 columns: ampliconName
, forwardSequence
,reverseSequence
.
Option 2. One line per primer with 3 columns: primerName
, sequence
, pool
.
General
All text is case sensitive.
Any line starting with '#' is ignored. This can be used to add a header line with column names.
Every line must have the same number of columns and format (except those starting with '#').
Any number of spaces can separate the columns. A value within a single column should not have any space.
BED format
Per standard BED conventions, sequence coordinates are given as 0-based, half-open intervals, such that the chromStart
field (2nd column) contains the first nucleotide in the primer binding site and the last nucleotide in the primer binding site is the value in the chromEnd
field (3rd column) minus 1.
chrom
field must contain a sequence identifier that matches the header of the FASTA file containing the sequence that the coordinates are relative to.
Multiple sequence identifiers (chrom
) are permitted within one file.
Primer name
primerName
must be unique and encode the name of the amplicon for which the primer is designed, the direction tag indicating which side of the amplicon, left or right, the primer belongs to, and an optional indicator that the primer is an alternative primer for that amplicon.
In addition to _LEFT
and _RIGHT
, we permit _L
and _R
as direction tags in primerName
. Any text after the direction tag should be separated by an underscore.
Text in primerName
before the direction tag is considered to be an amplicon identifier. Ensure that the text of the amplicon identifier is unique for that amplicon and that the direction tag occurs only once in primerName
.
Each amplicon must have at least one left and right primer (including alternative primers) associated with it.
Alternative primers are used to bind to locations that avoid sequence variation in the default primer binding site that may disrupt hybridization. An amplicon may have an arbitrary number of alternative primers (as long as the primer name is unique), but most amplicons will have none. Alternative primers are indicated by the presence of the _alt
after the direction tag in primerName
, followed by optional text to distinguish between different alternative primers, such as a number.
Examples of valid primer names:
MY_SEQUENCE_434_A_LEFT
virus1_L
amplicon_4934m_RIGHT_alt
amplicon_4934m_RIGHT_alt1
amplicon_4934m_R_altprimerB
Examples of invalid primer names:
LEFT_MY_SEQUENCE_434_A
virus1_l
amplicon_4934m_RIGHT_L
A BED-like tab-separated value (TSV) file with no header row, consisting of the following columns:
chrom
: each sequence name as it appears in Custom Reference FASTA
chromStart
: start position (always set to 0)
chromEnd
: end position (sequence length)
genomeName
: full name of the virus the sequence belongs to (e.g. Monkeypox virus clade II)
(optional) segmentName
: how this sequence is labeled within the virus (e.g. Segment 4 (HA)). Set to 'Full' if the sequence is the full genome
This file affects how sequences are labeled in the output.
Sequence names must match those in Custom Reference FASTA. The same set of sequences must appear in both.
If there are multiple viruses, their names should be unique. For example, if there are multiple Influenza genomes, they should not be labeled with the same virus name in the 4th column.
If the Custom Reference FASTA includes sequences from multiple segments, it is recommended to provide this BED file. Otherwise, each segment will be treated independently and not all of them may be used as reference.
Describes the report that can be viewed from the Summary link on the Reports tab of a completed analysis.
At the top of the report, after the app version display, is the Metrics by Sample table which provides a top-line summary of each of the analyzed samples.
The first element is a button that will trigger downloading of a FASTA-formatted file containing all consensus sequences generated across all samples.
The "Download CSV" button allows for downloading the contents of the table as a text comma-separated value (CSV) file. Note that for fields with multiple entries, these entries will be combined as a semicolon-separated list in the corresponding fields in the CSV file.
Next is the table itself, which contains one row per sample. The various genomes generated for each sample are nested as sub-rows within this row.
The table contains one row per sample and the following columns:
Sample: The name of the BaseSpace sample analyzed. The sample name is a clickable link that will take you directly to the Result Report for that sample.
Num genomes: The number of genomes chosen during the reference selection stage of the pipeline
Genomes generated: The names of each genome chosen during the reference selection stage. If the percentage of callable bases (callable bases are defined as genomic positions with read coverage above the minimum read coverage depth for consensus sequence generation, 10x by default) for a genome is below the minimum percentage of consensus sequence generated to label as confident (5% by default), the cell is highlighted in yellow to indicate that there is only marginal evidence that the indicated genome is present in the sample and should be treated with caution. For amplicon experiments, if the sample is considered to have insufficient titer for VC because the percentage of detected amplicons is below the minimum percentage required for reliable variant calling (80% by default), cells are highlighted in orange. For genomes for which a consensus sequence was generated, clicking on the name of that genome initiates a download of a FASTA file containing the consensus sequences of that genome only.
% callable bases: The percentage of the selected reference genome whose bases are considered "callable." Callable bases are those for which reliable variant calling can be performed and therefore for which the software can output a base call. Callable bases are defined as genomic positions with read coverage above the minimum read coverage depth for consensus sequence generation (10x by default). Note that genomic positions below the confidence threshold are hard-masked with "N" characters to avoid reference bias (inclusion of a reference base when the actual base cannot be accurately determined). Note that this percentage is calculated over the lengths of the reference genome(s), not the reported consensus sequence(s).
Status: The overall outcome of the analysis for this virus
Full analysis (consensus, VC) means that the sample analysis completed normally, that a sufficient number of amplicons were detected to ensure reliable variant calling (amplicon experiments only), and that the percentage of callable bases was above the minimum percentage of consensus sequence generated to label as confident (5% by default)
Low confidence means that there is at lease one callable base but the overall percentage of callable bases was below the minimum percentage of consensus sequence generated to label as confident (5% by default)
No callable bases indicates that zero positions in the indicated reference genome were callable and no consensus sequence is therefore provided.
Consensus FASTA: This column contains links to download a FASTA-formatted text file containing all of the consensus genomes generated for a sample. If no consensus genomes were generated for a sample, this column contains "N/A."
Input read count: The number of reads (or read pairs / clusters for paired-end samples) in the sample.
Mapped read count: The number of reads that could be mapped to any reference genome.
Unmapped reads: Displays buttons that initiate downloads of gzipped FASTQ files containing reads that could not be mapped to any reference genomes.
Raw Contigs: Displays a button that initiates a download of a FASTA file containing all contigs generated during the de novo assembly step of the pipeline. If a contig could be mapped to a reference genome the contig name contains information about the reference genome they aligned to.
This table contains the results of the Pangolin analysis performed on the generated consensus sequences across all samples. Pangolin is run if the "Enable Pangolin" box is checked on the input form and one of the following is true:
'Enrichment Panel' is set to a non-custom panel (e.g. VSP) and a consensus sequence was generated using SARS-CoV-2 as reference
'Amplicon Primer Set' is set to a non-custom set with SARS-CoV-2 as reference (e.g. SARS-CoV-2, ARTIC v5.3.2 primers) and a valid consensus sequence was generated
Either 'Enrichment Panel' or 'Amplicon Primer Set' is set to 'Custom'. In this case, Pangolin is applied to every consensus sequence generated for the sample since the software assumes all of them to be potentially SARS-CoV-2 sequences.
The Pangolin report contains a "Download CSV" button which allows the user to download the contents of the report as a text CSV file.
This table contains the results of the NextClade analysis performed on the generated consensus sequences across all samples. NextClade is run if the "Enable NextClade" box is checked on the input form and one of the following is true:
'Enrichment Panel' is set to a non-custom panel (e.g. VSP) and a consensus sequence was generated using a reference with NextClade dataset available.
'Amplicon Primer Set' is set to a non-custom set with a reference with NextClade dataset available (e.g. SARS-CoV-2, ARTIC v5.3.2 primers) and a valid consensus sequence was generated.
Either 'Enrichment Panel' or 'Amplicon Primer Set' is set to 'Custom' and one or more NextClade datasets are selected under 'Custom Reference'. In this case, each of the selected NextClade datasets is applied to each consensus sequence generated for the sample. This may result in multiple NextClade results for each consensus sequence, some of which may not be meaningful (e.g. "flu_h1n1pdm_ha" dataset applied to a NA segment of an Influenza genome).
The NextClade Report contains a button labeled "Group table by" with a drop-down menu allowing the user to group the results by various fields, including "None". The default is "Dataset" which means that all of the results for each NextClade dataset will be grouped together. For example, if a user is only interested in phylogenetic analysis performed on the HA segment of Influenza A H1N1, these results for each sample can be viewed together in the "flu_h1n1pdm_ha" collapsible group.
The NextClade report also contains a "Download CSV" button which allows the user to download the contents of the report as a text CSV file.
In addition to the built-in options, DRAGEN Targeted Microbial supports the use of custom reference genomes and primer definitions. These files must be uploaded to a BaseSpace Project before they can be used. See for more information about importing files into BaseSpace. These files can be used for both Enrichment and Amplicon libraries, when choosing the 'Custom' option for 'Enrichment Panel' or 'Amplicon Primer Set', respectively. Expand the 'Custom Reference' settings block to access the options for custom files. The following controls are applicable to the specified experiment type:
Custom Reference FASTA for Consensus Generation (required)
Custom Reference BED (optional)
Custom Reference FASTA for Consensus Generation (required)
Custom Reference BED (optional)
Custom PCR Primer Definitions (optional)
The user may provide one or more reference genomes as the target for read alignment (and as the basis for generating consensus sequences). At a minimum, the user must provide a FASTA file containing the sequences of the reference genomes. The software will generate the required DRAGEN hash tables and other auxiliary files automatically, so there is no need to process the FASTA file with a separate app. Use the 'Custom Reference FASTA for Consensus Generation' control to select the previously-uploaded FASTA file containing the reference sequences.
Optionally, a genome definition BED file may also be provided, which tells the software more information about each sequence, such as a human-readable common name to be used in the reports. For multi-segment genomes such as Influenza, the genome definition file provides the segment name of each sequence and indicates that all the segments of a single genome belong together. Use the 'Custom Reference BED' control to select the previously-uploaded BED file containing the genome definition. See the following page for a description of the format of the genome definition file:
For amplicon experiments, the user may optionally provide a file that defines the primer sequences or locations. The primers defined in this file are used for two purposes:
The primer binding locations are used to trim reads, which eliminates sequence data that may be contributed by the primer sequences themselves (which we do not want) from sequence data contributed by the sample (which we do want). This is important to avoid reference bias that can depress the observed allele frequency of sequence variants in primer binding sites.
The primers are matched to define the boundaries of the expected amplicons resulting from the PCR reaction. The read coverage within the unique (non-overlapping) regions of these amplicons is used to determine whether or not each amplicon is reliably observed. The fraction of observed amplicons is a function of the concentration of the sample, and is used to determine whether or not sufficient material exists within the sample to reliably and accurately call variants and generate a consensus sequence. See this page for a more in-depth discussion:
Use the 'Custom PCR Primer Definitions' control to select the previously-uploaded primer definition file. The allowed formats for this file are described here:
Detected Amplicons (only if 'Experiment Type' is set to 'Amplicon'): The number of amplicons detected over the total number of amplicons expected for that sequence. The percentage of amplicons detected is used to to determine if the sample is sufficient quality for variant calling. See for more details.
Insufficient titer for VC will only be present for an amplicon experiment and indicates that the number of detected amplicons was below the minimum percentage (default 80%) required for reliable variant calling. See for more details.
The table in the Pangolin report is derived from the output of the Pangolin software. Please see the Pangolin documentation for more details: . Sequences with a bad Pangolin QC status are highlighted in yellow.
The table in the NextClade report is derived from the output of the NextClade software. Please see the NextClade documentation for more details: . Sequences with a bad NextClade QC status are highlighted in yellow.
Reference | Example | Required input | Note |
---|
Single non-segmented genome | Zika | Primer set |
Single segmented genome | All 8 segments from one Influenza A genome | Primer set |
Multiple non-segmented genomes | Multiple genomes of Zika | Reference BED, Primer set | Reference BED must be provided to make it clear that the reference sequences are not segments in the same genome. Otherwise, the pipeline will assume this is a single segmented genome (above). If multiple genomes remain after reference selection, the genome with the best per-amplicon coverage will be considered for sample filtering. |
Multiple segmented genomes | A collection of Influenza A and B genomes | Reference BED, Primer set | Reference BED must be provided to specify which sequences belong to the same genome. Otherwise, the pipeline will assume this is a single segmented genome. If multiple genomes remain after reference selection, the genome with the best per-amplicon coverage will be considered for sample filtering. |
Amplicon sequencing, especially of RNA viruses, requires additional bioinformatics processing to ensure maximum quality of the resulting data.
In RT-PCR, a reverse transcriptase enzyme first generates cDNA molecules using the RNA molecules in the sample as templates, before amplifying the cDNA sequences using a DNA polymerase enzyme during PCR. These amplified cDNA sequences are then further processed to generate the sequencing libraries. Both of these enzymes can potentially introduce an incorrect base into a sequence, generating a position where the resulting sequence does not match the sequence in the sample -- that is, an error.
Reverse transcriptases exhibit error rates that are multiple orders of magnitude higher than those of DNA polymerases.
When large numbers of nucleic acid molecules are present in a reaction, these individual misincorporation errors are largely uncorrelated and appear at very low frequencies, so that they are typically ignored by variant callers.
However, when the number of incoming nucleic acid molecules is small, such as for a low-titer virus sample, an error that occurs during the RT step or early in the PCR reaction can, as a result of sampling noise, be amplified to high frequencies in the resulting sequencing libraries. When the variant caller encounters such a position, it will be treated as a sequence variant, since it is a true sequence variant in the context of the library provided to the instrument. As a result, these artifactual sequence variants often have high allele frequency and very good quality scores, which makes them very difficult to detect and remove. This can result in a false positive variant call that, at a sufficiently high allele frequency, will also be incorporated into the consensus sequence. It is also possible for a true sequence variant to have its allele frequency depressed by this same process (if the error results in a reversion to the reference sequence), but this is much less common.
Since it is difficult to identify enzyme-introduced false variants after the fact, we instead take a pre-emptive approach to ensuring data quality. As noted above, sampling noise as a function of molecular abundance is the mechanism responsible for boosting of the frequency of individual enzymatic errors into artifactual variants, and therefore the magnitude of this effect is largely a function of the concentration of the nucleic acids in the reaction. Therefore, the software first attempts to determine whether there is sufficient sample material present before proceeding with variant calling and consensus sequence generation.
To determine this, the software takes advantage of the fact that the probability of each amplicon being amplified is a function of the nucleic acid concentration, with higher concentrations leading to a higher probability of amplification. By counting the observed proportion of amplicons with detectable sequence coverage, we can estimate this probability and compare it to an experimentally-determined threshold that corresponds to the minimum concentration needed to produce reliable variant calls.
To compute this, we calculate the number of amplicons with at least 1x coverage for at least 90% of the non-overlapping portion of the amplicon sequence. The 1x coverage threshold used here is fixed and independent of the minimum read coverage depth for consensus sequence generation which defaults to 10x. The number of amplicons that meet this threshold is then divided by the total number of amplicons in the experiment, which is the number of amplicons whose location falls in reference sequences selected for short read alignment. If the resulting fraction is at least 80%, the sample is considered to have sufficient material for accurate variant calling and the variant calling and consensus sequence generation steps are performed. If it is below this threshold, the sample is not processed further to avoid spurious variant calls. The user can override the 80% threshold in the "Minimum percentage of amplicons with at least 90% coverage ≥ 1x to enable variant calling and consensus sequence generation" control in the "Advanced Workflow Settings" section. See App Settings.
Note: Some files may not be generated depending on user inputs and pipeline outcome
For each sample, the pipeline generates a directory named after the sample. This directory contains the following subdirectories:
consensus/
{sample_name}_sample_consensus.fasta
: Contains all hard-masked consensus sequences for the sample. Regions with coverage below minimum coverage depth for consensus sequence generation (10x by default) are considered not callable and are therefore “hard-masked” with letter N. Variant calling is not applied to these regions. If the user selected specific VSP or RVOP organisms to be reported, this file excludes consensus sequences that are generated but do not belong to the selected organisms.
{sample_name}.consensus_hard_masked_sequence.fa
: Identical to {sample_name}_sample_consensus.fasta
, except for sequence headers. Moreover, even if the user selected specific VSP or RVOP organisms to be reported, this file contains all consensus sequences, including those that do not belong to the selected organisms
{sample_name}.consensus_soft_masked_sequence.fa
: Identical to {sample_name}.consensus_hard_masked_sequence.fa
, except low-coverage regions are “soft-masked” with lower-case letters that match the reference. Variant calling is not performed in these regions.
{sample_name}{virus_name}_virus_consensus.fasta
: Contains hard-masked consensus sequences generated for a particular virus. If the virus is not segmented (i.e. one reference sequence for the virus), this file contains a single sequence and is identical to {sample_name}{virus_name}{segment_name}{sequence_accession} consensus.fasta.
{sample_name}_{virus_name}_{segment_name}_{sequence_accession}_consensus.fasta
: Contains a hard-masked consensus sequence generated with a particular reference sequence.
{sample_name}.consensus_from_vcf.log
: Log file generated during consensus sequence generation.
contig/
{sample_name}_sample_contig.fasta
: Contains all de novo assembled contigs generated for the sample.
{sample_name}_unmapped_contig.fasta
: Contains de novo assembled contigs that could not be mapped to any reference sequence. Because de novo assembly is reference-free, these contigs may correspond to sequences that are too diverged from those in the reference database or sequences not included in the database.
{sample_name}_{virus_name}_virus_contig.fasta
: Contains de novo assembled contigs that mapped to a particular virus.
{sample_name}_{virus_name}_{segment_name}_{sequence_accession}_contig.fasta
: Contains de novo assembled contigs that mapped to a particular reference sequence, which resulted in choosing the reference sequence for short-read alignment and generating {sample_name}_{virus_name}_{segment_name}_{sequence_accession}_consensus.fasta.
{sample_name}_reference_selection.log
: Log file generated during reference selection.
map_align/
{sample_name}_unfiltered_tumor.bam
or {sample_name}_unfiltered_tumor_primertrim_with_unmapped_reads.bam
: Short reads mapped to all selected reference sequences. If a primer set is available and properly mapped to the reference sequences, {sample_name}_unfiltered_tumor_primertrim_with_unmapped_reads.bam
is provided as output. Its reads have primer sequences trimmed based on primer binding site coordinates.
{sample_name}-unmapped_S1_L001_R1_001.fastq.gz, {sample_name}-unmapped_S1_L001_R2_001.fastq.gz
: Short reads that do not map to any selected reference sequences. These may be used to find organisms not reported by the pipeline.
variant_calling/
{sample_name}.consensus_filtered_variants.vcf.gz
: Contains variant calls that passed consensus filter and were therefore applied to consensus sequences. They are a subset of variants listed in {sample_name}.hard-filtered.vcf.gz.
{sample_name}.consensus_filtered_variants_vcf_stats.txt
: Summarizes all variant calls in {sample_name}.consensus_filtered_variants.vcf.gz. Outputted by bcftools stats.
{sample_name}.consensus_filtered_variants_summary.csv
: Describes each variant call in {sample_name}.consensus_filtered_variants.vcf.gz.
{sample_name}.hard-filtered.vcf.gz
: Contains all variant calls.
{sample_name}.consensus_input_vcf_stats.txt
: Summarizes all variant calls in {sample_name}.hard-filtered.vcf.gz. Outputted by bcftools stats.
{sample_name}.consensus_all_variants_summary.csv
: Describes each variant call in {sample_name}.hard-filtered.vcf.gz.
metrics/
{sample_name}_num_reads.tsv
: Reports number of input reads, reads filtered out at each pre-processing step, reads mapped to each selected reference sequence, etc.
{sample_name}_metadata.json
: Reports parameters, read counts, amplicon counts, analysis results, and other metadata.
{sample_name}.consensus_metrics.csv
: Reports consensus metrics (e.g. total length of pre-trimmed sequence, fraction of masked bases, number of callable bases) for each generated consensus sequence
{sample_name}.consensus_coverage_from_filtered_bam.tsv
: Reports base-pair-resolution read coverage for all reference sequences based on short-read map/align step. Its three columns correspond to: chrom/accession, base position, coverage.
{sample_name}.consensus_callable_regions_from_filtered_bam.bed
: Reports callable regions in all reference sequences based on base-pair-resolution read coverage and minimum coverage depth for consensus sequence generation (10x by default). Bases outside of these regions are masked in consensus FASTA.
amplicon/
{sample_name}_processed_non_overlapping_amplicon.bed
: Lists all non-overlapping amplicon regions (i.e. covered with exactly one amplicon). If a custom primer set is provided, this file also lists selected reference sequences lacking amplicons. While amplicons are defined based on primer binding sites, for viruses like Influenza, reference sequences often lack primer binding sites, which are located at sequence ends. This results in defining fewer or sometimes no amplicons for an entire viral genome. To avoid this, each reference sequence without any amplicons defined is considered an amplicon and is listed in this file. All regions in this file are used for amplicon detection to infer sample concentration and determine if it is sufficient to apply variant calling and consensus sequence generation.
{sample_name}_calculate_amplicon_coverage.csv
: Reports coverage metrics (e.g. median coverage, fraction of bases with at least 1x coverage) for each non-overlapping amplicon region listed in {sample_name}_ processed_non_overlapping_amplicon.bed.
{sample_name}_generate_all_primer_bed.log
: Log file generated while defining amplicons for selected reference sequences and writing relevant BED files.
tertiary/
nextclade_{sample_name}_{sequence_accession}_{dataset_name}.csv
: CSV output file generated by NextClade given a consensus sequence (generated with the specified sequence as reference) and a NextClade dataset.
nextclade_{sample_name}_{sequence_accession}_{dataset_name}.tsv
: Same as nextclade_{sample_name} _{sequence_accession}_{dataset_name}.csv
except in TSV format.
nextclade_{sample_name}_{sequence_accession}_{dataset_name}.json
: Same as nextclade_{sample_name} _{sequence_accession}_{dataset_name}.csv
except in JSON format.
nextclade_{sample_name}_{sequence_accession}_{dataset_name}_log.txt
: Log file generated by NextClade given a consensus sequence (generated with the specified sequence as reference) and a NextClade dataset.
pangolin_{sample_name}_{sequence_accession}_lineage_report.csv
: CSV output file generated by Pangolin given a consensus sequence (generated with the specified sequence as reference) as input.
pangolin_{sample_name}_{sequence_accession}_log.txt
: Log file generated by Pangolin given a consensus sequence (generated with the specified sequence as reference) as input.
reference/
reference.bed
: Describes all reference sequences. If a custom reference was provided, sequence names may appear different in this BED file.
reference.json
: Same as reference.bed
but with more detail. If any of the sequences were renamed during the pipeline, this file provides the mapping between the original and renamed versions.
Brief description of Summary and Result reports and an explanation of their contents
The app produces a summary report as well as result reports for each of the samples analyzed. See the links below for a description of each.
Describes the controls on the Input Form and their function
Item name | Description | Choices | Default | Required |
---|---|---|---|---|
Describes the reports that can be viewed from the individual sample links on the left side of the reports tab or by clicking on sample names in the Metrics by sample table.
At the top of the report is version information for the App and any third-party components.
Two buttons provide the ability to download relevant FASTA-formatted text files for this sample. The "Consensus" button initiates a download of a FASTA file containing all consensus sequences generated for this sample. The "Contig" button initiates a download of a FASTA file containing all assembled contigs for this sample.
The metrics by virus table contains information about each viral genome generated. Each row summarizes all sequences assigned to that virus. In the case of multi-segment viruses like Influenza, a row will summarize information across all segment sequences generated for a single viral genome. It contains buttons to download the contents of the table as a CSV, JSON or PDF file. The table itself contains rows for every virus with at least one generated genome in the sample. It contains the following columns:
Virus: The name of the virus. For custom references, this will be the part of the FASTA header before the first whitespace character for the corresponding reference sequence if no custom genome definition file is provided. If a custom genome definition file is provided, this will be the value of the genomeName
column that corresponds to the selected reference (matched by the value in the chrom
column of the genome definition file and the part of the FASTA header before the first whitespace character).
% callable bases: The percentage of the selected reference genome whose bases are considered "callable." Callable bases are those for which reliable variant calling can be performed and therefore for which the software can output a base call. Callable bases are defined as genomic positions with read coverage above the minimum read coverage depth for consensus sequence generation (10x by default). Note that genomic positions below the confidence threshold are hard-masked with "N" characters to avoid reference bias (inclusion of a reference base when the actual base cannot be accurately determined). Note that this percentage is calculated over the lengths of the reference genome(s), not the reported consensus sequence(s).
Status: The overall outcome of the analysis for this virus
Full analysis (consensus, VC) means that the sample analysis completed normally, that a sufficient number of amplicons were detected to ensure reliable variant calling (amplicon experiments only), and that the percentage of callable bases was above the minimum percentage of consensus sequence generated to label as confident (5% by default)
Low confidence means that there is at lease one callable base but the overall percentage of callable bases was below the minimum percentage of consensus sequence generated to label as confident (5% by default)
No callable bases indicates that zero positions in the indicated reference genome were callable and no consensus sequence is therefore provided.
Median coverage: The median coverage value (in number of reads overlapping each position) over the entire reference genome (not just the generated consensus sequence).
Consensus FASTA: A download link to a FASTA-formatted text file containing all the consensus sequences generated for this virus.
This table summarizes the results for each sequence generated for the sample. For multi-segment viruses such as Influenza, there will may be multiple sequences detected for a given virus. For single-segment viruses there will typically be only one sequence per virus. It contains buttons to download the contents of the table as a CSV, JSON or PDF file. The table itself contains rows for every sequence. It contains the following columns:
Virus: The name of the virus. For custom references, this will be the part of the FASTA header before the first whitespace character for the corresponding reference sequence if no custom genome definition file is provided. If a custom genome definition file is provided, this will be the value of the genomeName column that corresponds to the selected reference (matched by the value in the accession column of the genome definition file and the part of the FASTA header before the first whitespace character).
Segment: The name of the genome segment to which the sequence belongs. For viruses with a single segment, the name of the segment will typically be "Full".
Accession: The accession number or other short unique identifier for the sequence. If using a custom genome definition BED, this value is taken from the first column (chrom
) in the definition file. If using a custom reference without a genome definition file, the value is taken from the part of the FASTA header before the first whitespace character.
% callable bases: The percentage of the selected reference sequence whose bases are considered "callable." Callable bases are those for which reliable variant calling can be performed and therefore for which the software can output a base call. Callable bases are defined as genomic positions with read coverage above the minimum read coverage depth for consensus sequence generation (10x by default). Note that genomic positions below the confidence threshold are hard-masked with "N" characters to avoid reference bias (inclusion of a reference base when the actual base cannot be accurately determined). Note that this percentage is calculated over the lengths of the reference sequence, not the reported consensus sequence.
Median coverage: The median coverage value (in number of reads overlapping each position) over the entire reference sequence (not just the generated consensus sequence).
Consensus sequence length: The length of this consensus sequence. The reported length is the length of the hard-masked sequence after trimming any leading and trailing masked regions (if trimming is active).
# callable bases: The number of positions in the reference sequence above the minimum read coverage depth for consensus sequence generation (default 10x). In other words, the number of positions not masked. This may not be equal to the number of unmasked positions in the final consensus sequence since insertions and deletions are applied after masking.
Consensus FASTA: A download link to a FASTA-formatted text file containing this consensus sequence.
This stacked bar plot contains information about the outcome of the pre-processing steps (read QC, trimming, de-hosting) as well as the alignment step. It contains counts of reads that fall into the following categories:
Removed in QC: Reads that failed to meet the minimum quality thresholds and were excluded from further processing.
Removed in trimming: Reads that were removed in the initial sequence-based primer trimming step and were excluded from further processing.
Removed in de-hosting: Reads that were removed in the de-hosting step and excluded from further processing. De-hosting is the process of removing reads that may originate from the host organism. Currently only human hosts are supported. De-hosting reads improves the quality of downstream analysis and helps ensure that human sequences are not included in the output BAM files.
Unmapped: Reads that were not aligned to any reference genomes.
Mapped. Reads that were mapped to at least one reference genome.
A column plot displaying the numbers and percentages of all reads that aligned to each reference sequence with at least one mapped read. The columns are labeled by both virus and segment name (if available) on the x-axis, and the y-axis is the read count for each sequence.
Displays a trace of the read coverage over each reference sequence. The drop-down menu in the upper left allows the user to switch between viruses. If multiple segment sequences are generated for a single virus, their corresponding coverage plots will be displayed in a vertically stacked fashion. The black trace represents the read coverage, with the coverage depth in number of reads on the left y-axis and the position in the reference sequence on the x-axis.
The minimum read coverage depth for consensus sequence generation (default 10x) is plotted as a dashed orange line across the plot, to easily visualize locations where coverage drops below the threshold (which will be masked in the consensus sequence) and where the coverage is above the threshold (which will be reported in the consensus sequence).
The median coverage is plotted as a dashed teal line across the plot.
By default, sequence variants representing differences between the consensus sequence and the reference sequence are also plotted, with allele frequency on the right y-axis. The colors and symbols represent different sequence variant types. See the figure legend for details.
The "Show log-scale" toggle switch allows the user to switch between logarithmic and linear scales for the coverage (left) y-axis.
The "Show Median" toggle switch allows the user to turn the median coverage line on and off.
The "Show Sequence Variants" toggle switch allows the user to turn the plotting of sequence variants on and off.
This table contains the results of the Pangolin analysis performed on the generated consensus sequences. Pangolin is run if the "Enable Pangolin" box is checked on the input form and one of the following is true:
'Enrichment Panel' is set to a non-custom panel (e.g. VSP) and a consensus sequence was generated using SARS-CoV-2 as reference
'Amplicon Primer Set' is set to a non-custom set with SARS-CoV-2 as reference (e.g. SARS-CoV-2, ARTIC v5.3.2 primers) and a valid consensus sequence was generated
Either 'Enrichment Panel' or 'Amplicon Primer Set' is set to 'Custom'. In this case, Pangolin is applied to every consensus sequence generated for the sample since the software assumes all of them to be potentially SARS-CoV-2 sequences.
The Pangolin report contains a "Download CSV" button which allows the user to download the contents of the report as a text CSV file.
This table contains the results of the NextClade analysis performed on the generated consensus sequences. NextClade is run if the "Enable NextClade" box is checked on the input form and one of the following is true:
'Enrichment Panel' is set to a non-custom panel (e.g. VSP) and a consensus sequence was generated using a reference with NextClade dataset available.
'Amplicon Primer Set' is set to a non-custom set with a reference with NextClade dataset available (e.g. SARS-CoV-2, ARTIC v5.3.2 primers) and a valid consensus sequence was generated.
Either 'Enrichment Panel' or 'Amplicon Primer Set' is set to 'Custom' and one or more NextClade datasets are selected under 'Custom Reference'. In this case, each of the selected NextClade datasets is applied to each consensus sequence generated for the sample. This may result in multiple NextClade results for each consensus sequence, some of which may not be meaningful (e.g. "flu_h1n1pdm_ha" dataset applied to a NA segment of an Influenza genome).
The NextClade Report contains a button labeled "Group table by" with a drop-down menu allowing the user to group the results by various fields, including "None". The default is "Dataset" which means that all of the results for each NextClade dataset will be grouped together. For example, if a user is only interested in phylogenetic analysis performed on the HA segment of Influenza A H1N1, these results for each sample can be viewed together in the "flu_h1n1pdm_ha" collapsible group.
The NextClade report also contains a "Download CSV" button which allows the user to download the contents of the report as a text CSV file.
DRAGEN Microbial Enrichment Plus offers a dedicated informatics solution with flexible analysis options for Illumina Infectious Disease and Microbiology target-capture enrichment panel kits. The app delivers easy-to-use, powerful secondary analysis of Illumina sequencing data, with workflows for sample QC, viral WGS (whole-genome sequencing), pathogen detection and quantification, and antimicrobial resistance (AMR) marker profiling. It also supports user-defined microorganism reporting thresholds and custom reference sequence analysis.
Product Page | Panel Summary |
---|
FASTQ files
(optional)
(if applicable)
(if applicable)
(all panels except where noted, (*) indicates applicable to custom reference sequence analysis)
Read QC* (optional)
Dehosting* (human read removal)
Sample QC (sample composition and enrichment factor calculations. Internal control required to calculate the enrichment factor) – RPIP, UPIP, VSP V2
Microorganism classification (configurable sensitivity) - RVOP, VSP, VSP V2
Microorganism detection (alignment, consensus generation, variant calling)
Microorganism quantification (quantitative internal control required) – RPIP, UPIP, VSP V2
Microorganism reporting thresholds (proprietary algorithms or user-defined reporting logic)
Bacterial AMR marker analysis (nucleotide and protein alignment, consensus generation, variant calling and annotation) – RPIP, UPIP
Viral AMR marker analysis (variant calling and annotation) – RPIP, RVOP, VSP, VSP V2
Viral clade and lineage prediction (Pangolin, Nextclade) – RPIP, RVOP, VSP, VSP V2
Result filters (user-specified filters applied)
Reporting*
Analysis-level outputs: XLSX, HTML, ZIP
Sample-level outputs: JSON, HTML, FASTA (consensus sequences), VCF (viral variants)
DRAGEN Microbial Enrichment Plus is a secondary analysis tool for research use only. Further interpretation, statistical analysis, and downstream analysis of results may be necessary.
A: The enrichment protocols can create a several thousand fold increase in the abundance of the targeted viral species. However, it is important to keep in mind that in many sample types, especially clinical, wastewater, or environmental samples, viral RNA or DNA makes up a tiny proportion of the total nucleic acids present, with the remainder dominated by host (human) or bacteria/archaea. So even with a dramatic enrichment of abundance over what you would obtain without enrichment, the percentage of viral reads can still be low. E.g. you may have a sample with only 2% viral reads, but without enrichment you might have only obtained 0.1% viral reads. If it is low abundance after enrichment, it is likely extremely low abundance prior to enrichment.
A: The 10x threshold is applied per-nucleotide. Any positions below 10x coverage will be hard-masked with "N".
A: Correct, we only align to a limited number of reference sequences for each virus type, so the sequence accession in the consensus genomes (and coverage plots, etc) merely reflects the best match chosen from that subset. There could be sequences in RefSeq that are a closer match. Furthermore, strain typing is not necessarily as simple as choosing the closest matching genome; there are further complexities that can go into it, and we have not systematically developed or tested any strain typing capability to date. The noted message is to warn users that the sequence accession in the consensus genome does not necessarily reflect the true phylogeny of the organisms in the sample and should not be taken as such.
A: For each de novo assembled contig, we aim to find the best matching reference sequence rather than an entire reference genome. If the best match for one contig is a reference sequence from one subtype and the best match for another contig is a reference sequence from another subtype, then we will report them as such. This is not necessarily indicative of a mixed infection, reassortment, or error. It is usually reflective of how similar certain segments can be across different subtypes.
Influenza A viruses are classified into different subtypes based on the hemagglutinin (HA) and neuraminidase (NA) proteins, which are encoded by segments 4 and 6, respectively. Therefore, we recommend focusing on those segments to infer the subtype. If there is a sequence generated from segment 8 of an H3N2 genome but all the rest of the consensus sequences are generated from reference sequences from an H1N1 genome (indicating H1 and N1 subtypes), then the sample likely contains H1N1, not H3N2. One possible explanation is that segment 8 from H1N1 and segment 8 from H3N2 were both good matches for a particular contig but the one from H3N2 was a slightly better match and therefore chosen as final reference. Similarly, if there is a sequence generated from segment 4 of an H1N1 genome (indicating H1 subtype) and a sequence generated from segment 6 of an H5N1 genome (indicating N1 subtype), then the sample likely contains H1N1, not H5N1.
A: The denominator in the "Detected Amplicons" columns is based on the reference sequences selected based on de novo assembled contigs. Depending on the quality of the sample and/or reads, the assembler may not have enough data to generate a contig for some segments. Shorter segments are more likely to be missed. If only 7 segments are selected as final reference for short read alignment, then we expect 7 amplicons in total. If you believe that the sample should contain all 8 segments, you can download the contig FASTA file from our report page and submit it to to see if all 8 segments are present in the contig sequences.
One known issue is that chimeric reads can be generated during library preparation, which can lead to chimeric contigs, where the contig sequence contains sequences from more than one segment. This can result in missing an entire segment in the reference selection stage. A workaround may be to filter out chimeric reads from your FASTQ files before running the app.
Alternatively, you can force the app to use all 8 segments of a particular Influenza genome by providing a custom reference FASTA file with all 8 segment sequences and a custom reference BED file with the genomeName
column to set to the same value (e.g. Influenza A). This way, the app will not perform assembly and use all 8 segments as the reference sequences for short read alignemnt.
A: The "Detected Amplicons" column shows the number of amplicons detected over the total number of amplicons expected for that genome. The percentage of amplicons detected is used to infer if the sample is of sufficient quality for variant calling. The "% callable bases" column shows the percentage of the selected reference genome whose bases are above the minimum read coverage depth for consensus sequence generation, which is computed independent of amplicon coordinates. Both metrics are useful to assess the quality of the sample, but the percentage of detected amplicons is used by the app after short read alignment to filter out low-titer samples and the percentage of callable bases is not.
A: While there may be quite a few causes for the analysis to fail, some of the most common cases are that the custom database was not formatted correctly. Below are requirements for the Custom Reference FASTA For Consensus Generation:
Do not use Spaces in the file name, instead use an underscore "_"
Do not exceed 25 characters in the file name
File extension must be .fasta or .fa
Do not exceed the file size limitation: 16GB for a single file or 25GB for multiple files
Do not have duplicate entries
If providing a Custom Reference BED and/or Custom PCR Primer Definitions in BED format, the names in the first column of the BED file (chrom
) must match the names that appear in the FASTA (text after >
and before the first whitespace character) Please see this link on general guidelines to upload data to BaseSpace for more details: https://help.basespace.illumina.com/manage-data/import-data If you continue having issues, reach out to techsupport@illumina.com
Detected Amplicons (only if 'Experiment Type' is set to 'Amplicon'): The number of amplicons detected over the total number of amplicons expected for that sequence. The percentage of amplicons detected is used to to determine if the sample is sufficient quality for variant calling. See for more details.
Insufficient titer for VC will only be present for an amplicon experiment and indicates that the number of detected amplicons was below the minimum percentage (default 80%) required for reliable variant calling. See for more details.
The table in the Pangolin report is derived from the output of the Pangolin software. Please see the Pangolin documentation for more details: . Sequences with a bad Pangolin QC status are highlighted in yellow.
The table in the NextClade report is derived from the output of the NextClade software. Please see the NextClade documentation for more details: . Sequences with a bad NextClade QC status are highlighted in yellow.
The includes external control, contrived, and environmental samples prepared using the RPIP, UPIP, RVOP, VSP, and VSP V2 target-capture enrichment kits. Example custom reference sequence FASTA and BED files are also included.
A: Not necessarily. Your virus of interest may be present in the sample, but the app may not have generated a consensus sequence for it for various reasons. One reason could be that there are too few reads coming from that virus. Tools like DRAGEN Metagenomics can be used to characterize what is in the sample more broadly. Another reason could be that the virus in your sample is too divergent from the reference sequences used in the app. In such cases, we recommend downloading the contig FASTA file from our report page and submitting it to . If you do see a sequence that matches your virus of interest, you can provide that sequence to the app as a custom reference genome.
Save Results To
Project to run the analysis in
Required
Input Type
This app can accept samples or a project as input.
Samples: Select up to 60 individual samples, from any project(s)
Project: Select a single project containing up to 1536 samples. The app will analyze every FASTQ sample in that project (FASTQ datasets with QcStatus=QcFailed will be excluded)
Biosamples, Project
Biosamples
Required
Input Biosample
Select one or more samples to analyze. Either Input Samples or an Input Project can be selected - not both.
Required if Input Type is set to 'Samples'
Input Project
Select a Project containing up to 1536 samples to be analyzed. The analysis will process all samples from that project (FASTQ datasets with QcStatus=QcFailed will be excluded). There is currently no way to filter specific samples from a project. If the project contains more than 1536 Biosamples, the app will appear to launch, but then will immediately exit.
Required if Input Type is set to 'Project'
Experiment Type
This app can analyze samples generated from enrichment or amplicon sequencing experiments. Either can be selected - not both.
Enrichment, Amplicon
Enrichment
Required
Enrichment Panel
Select the enrichment panel used to generate the data. This determines the set of reference genomes the app uses. Different selection will produce different results. Choose 'Custom' to provide your own reference genomes below.
Viral Surveillance Panel (VSP)
Pan-Coronavirus Panel (Pan-Cov)
Respiratory Virus Oligo Panel (RVOP)
Custom
Required if Experiment Type is set to 'Enrichment'
Amplicon Primer Set
Select the virus genome to align to and primer set used to generate the data. Primer locations determine primer trimming locations and amplicon definitions. If processing SARS-CoV-2 data from a non-amplicon protocol, choose 'SARS-CoV-2, no primers'. Different selection will produce different results. Choose 'Custom' to provide your own reference genomes and primer set below
SARS-CoV-2, ARTIC v5.3.2 primers
SARS-CoV-2, ARTIC v4.1 primers
SARS-CoV-2, ARTIC v4 primers
SARS-CoV-2, ARTIC v3 primers
SARS-CoV-2, no primers
Influenza A, Universal primers
Influenza B, Universal primers
Influenza A and B, Universal primers
Chikungunya Virus, Grubaugh Lab primers
Chikungunya Virus, Illumina primers
Dengue Virus Serotype 1 (DENV1), 400-bp DengueSeq primers
Dengue Virus Serotype 1 (DENV1), Illumina primers
Monkeypox Virus (MPXV) Clade II, Grubaugh Lab primers
Respiratory Syncytial Virus (RSV), CDC primers
Respiratory Syncytial Virus (RSV), WCCRRI primers
Zika Virus, Grubaugh Lab primers
Custom
Required if Experiment Type is set to 'Amplicon'
Custom Reference: Custom Reference FASTA For Consensus Generation
Provide a custom reference FASTA to use for consensus generation. Either Enrichment Panel or Amplicon Primer Set must be set to Custom to enable this field.
Sequence names must be unique and must not contain any space. If there is any space in the FASTA header, the part before the first space is assumed to be the sequence name.
It is recommended to use the following in sequence names: alphabets, numbers, underscore (_
), hyphen (-
), parentheses ((
,)
), and period (.
). Otherwise, the sequence names may appear different in the output.
It is recommended to keep sequence names short (e.g. NC_045512.2). If needed, full names can be provided in the genomeName column of Reference BED below.
FASTA file name must not include any space, must not exceed 25 characters, and must use extension .fasta or .fa
Required if either Enrichment Panel or Amplicon Primer Set is set to 'Custom'
Custom Reference: Custom Reference BED
Provide a custom reference BED to describe each sequence in Custom Reference FASTA. See Genome definition BED file format
Optional if Enrichment Panel or Amplicon Primer Set is set to 'Custom'. Otherwise not applicable
Custom Reference: Custom PCR Primer Definitions
Provide a file defining primers used in amplicon sequencing. See Primer definition file formats
Optional if Amplicon Primer Set is set to 'Custom'. Otherwise not applicable
Custom Reference: NextClade Datasets
Select one or more available NextClade Datasets from the drop-down menu below. Hold ctrl/command key to select multiple or deselect.
Optional if either Enrichment Panel or Amplicon Primer Set is set to 'Custom'. Otherwise not applicable
Pangolin
Run Pangolin on applicable consensus genomes
True, False
True
Optional if any Enrichment Panel is selected, any SARS-CoV-2 Amplicon Primer Set is selected, or 'Custom' is selected for Enrichment Panel or Amplicon Primer Set. Otherwise not applicable
NextClade
Run NextClade on applicable consensus genomes. If providing Custom Reference, select NextClade Datasets above to enable. Otherwise not applicable NextClade
True, False
True
Optional if any Enrichment Panel is selected, if a genome with NextClade dataset available is selected for Amplicon Primer Set, or if 'Custom' is selected for Enrichment Panel or Amplicon Primer Set. Otherwise not applicable
Advanced Workflow Settings: Dehost
If checked: input FASTQs will be scrubbed of all human reads, before the Map/Align stage, so that the output BAM includes only viral reads.
True, False
True
Required
Advanced Workflow Settings: Trim Consensus Sequences
Remove any leading and trailing masked nucleotides from the resulting consensus sequences. Does not affect internal masked regions.
True, False
True
Required
Advanced Workflow Settings: Minimum percentage of amplicons with at least 90% coverage ≥ 1x to enable variant calling and consensus sequence generation
At low input concentrations, errors produced by the reverse transcriptase enzyme can propagate to high frequencies, leading to false positive sequence variants. Therefore, we attempt to infer the sample concentration from the amplicon coverage using this metric. If you wish to adjust this, we advise conducting internal studies to examine variant call reproducibility between replicates to determine a threshold that will produce acceptable quality levels for your application. Only applicable to amplicon sequencing where primers are defined. See Special considerations for amplicon sequencing with IMAP protocols
80.0%
Required if Experiment Type is set to 'Amplicon'
Advanced Workflow Settings: Minimum read coverage depth for consensus sequence generation
Genomic positions with read coverage below this threshold will be considered indeterminate and hard-masked in the final consensus sequence
10
Required
Advanced Workflow Settings: Minimum percentage of consensus sequence generated to label as confident
Consensus sequences with percentage of callable bases below this threshold will be considered 'low confidence'. Callability is defined based on minimum coverage depth for consensus sequence generation (above)
5.0%
Required
Additional DRAGEN Command Line Arguments: Additional DRAGEN Map/Align Command Line Arguments
USE AT YOUR OWN RISK. This field allows the user to add any DRAGEN command line argument, which can cause DRAGEN to:
Crash/fail/hang
Run for a very long time
Generate unexpected or invalid results
The app appends this input text to the DRAGEN command line after removing invalid characters (valid characters are alphanumeric plus ._-"'
). Note that there is no validation of the contents. If you use this field and the appsession aborts, the output*.log appsession log file may help to understand the cause of the failure.
Optional
Additional DRAGEN Command Line Arguments: Additional DRAGEN Variant Calling (Somatic) Command Line Arguments
USE AT YOUR OWN RISK. This field allows the user to add any DRAGEN command line argument, which can cause DRAGEN to:
Crash/fail/hang
Run for a very long time
Generate unexpected or invalid results
The app appends this input text to the DRAGEN command line after removing invalid characters (valid characters are alphanumeric plus ._-"'
). Note that there is no validation of the contents. If you use this field and the appsession aborts, the output*.log appsession log file may help to understand the cause of the failure.
Optional
Organisms to Report (VSP)
Only the checked organisms will be reported (consensus sequences and metrics). This will not affect the underlying bioinformatics pipeline, only which outputs are provided.
All VSP organisms
Optional if Enrichment Panel is set to 'VSP'. Otherwise, not applicable
Organisms to Report (RVOP)
Only the checked organisms will be reported (consensus sequences and metrics). This will not affect the underlying bioinformatics pipeline, only which outputs are provided.
All RVOP organisms
Optional if Enrichment Panel is set to 'RVOP'. Otherwise, not applicable
Launch the DRAGEN Microbial Enrichment Plus BaseSpace app, which can be found in the "Dragen" and "Infectious Disease + Microbiology" app collections.
Enter a name for the Analysis.
Choose either “Biosample” or “Project” as input type. When a Project is selected, the app will attempt to find all FASTQ files in that Project and run analyses on them. There is no FASTQ file limitation when reading Biosamples from a Project. However, 99 associated FASTQ files is the maximum allowed per analysis when providing Biosample input from a list.
Select a target-capture Enrichment Panel for the appropriate analysis options and default settings to populate. Only one enrichment panel can be selected per analysis. If Custom Panel is selected, the "Custom panel specification" section is enabled to allow entry of a reference FASTA file and (optionally) a reference BED file. See Custom reference FASTA and BED files for further details.
Under "Enrichment Panel Microorganism Reporting List", select from the available list to report All microorganisms (default), specify a Pre-defined subset of microorganisms (RPIP, UPIP only), or specify a User-defined microorganism reporting list and reporting thresholds.
If Pre-defined is selected, the Pre-defined specification section is enabled to allow specification of a pre-defined subset of microorganisms for the selected Enrichment Panel. This option is only available for RPIP and UPIP.
If User-defined is selected, the User-defined specification section is enabled to allow entry of a microorganism reporting list and reporting thresholds file in TSV or XLSX format. See Microorganism Reporting File format for further details.
Analysis Options:
Perform read QC (Quality Control)
If checked, reads are pre-processed using quality metrics before analysis.
If unchecked, read quality metrics are calculated, but reads are not trimmed or filtered before analysis.
Report bacterial AMR markers only
If checked, only bacterial AMR markers but no microorganisms are reported
This option is disabled if RVOP/RVEK, VSP, VSP V2 or Custom Panel is selected
This option is disabled if the "Report bacterial AMR markers only when an associated microorganism is reported" option is enabled
Report bacterial AMR markers only when an associated microorganism is reported
If checked, detected bacterial AMR markers are reported if the bacterial AMR marker passes a minimum reporting threshold and one or more associated microorganisms are also detected and reported
If unchecked, detected bacterial AMR markers are reported if the bacterial AMR marker passes a minimum reporting threshold
This option is disabled if RVOP/RVEK, VSP, VSP V2 or Custom Panel is selected
Report microorganisms and/or AMR markers that are below threshold
If checked, microorganisms and/or AMR markers below reporting thresholds are included in reports
If unchecked, only microorganisms and/or AMR markers above reporting thresholds are included in reports
This option is disabled if Custom Panel is selected
This option is disabled if the "Report bacterial AMR markers only when an associated microorganism is reported" option is enabled
Specify "Read classification sensitivity". This setting is used as a pre-alignment filtering step for RVOP/RVEK, VSP, and VSP V2 only. The default setting of 5 means that if less than 5 reads classify to the set of reference sequences belonging to a given virus, that virus will not be reported. On the other hand, if 5 or more reads classify to the set of reference sequences belonging to a given virus, read alignment will proceed and alignment-based thresholds will be used to determine whether that virus is reported. The read classification sensitivity can be set as low as 1 or as high as 1000. Lowering the read classification sensitivity threshold below 5 may significantly increase computational run time and is not recommended for most use cases.
Pangolin is currently enabled for all enrichment panels besides UPIP. For Custom Panel analyses, Pangolin will run on custom reference sequences with at least 3% coverage that meet these naming conventions:
If only a FASTA file is provided, Pangolin will run on sequences that have a header containing either SARS-CoV-2 or NC_045512
If both a FASTA and BED file are provided, Pangolin will run on sequences where the first column (chrom) contains NC_045512 or the fourth column (genomeName) contains SARS-CoV-2
Optionally, enable Nextclade to run when one of the following microorganisms is detected (RPIP, RVOP/RVEK, VSP, VSP V2 only):
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Influenza A virus (H1N1)
Influenza A virus (H3N2)
Influenza A virus (H5N1)
Influenza A virus (H5N6)
Influenza A virus (H5N8)
Influenza B virus (B/Victoria/2/87-like)
Influenza B virus (B/Yamagata/16/88-like)
Human immunodeficiency virus 1 (HIV-1)
Human respiratory syncytial virus A (HRSV-A)
Human respiratory syncytial virus B (HRSV-B)
Monkeypox virus (MPV)
Measles virus (MV)
Dengue virus (DENV), Dengue virus type 1 (DENV-1), Dengue virus type 2 (DENV-2), Dengue virus type 3 (DENV-3), Dengue virus type 4 (DENV-4)
Select a quantitative Internal Control (IC) from the available list (RPIP, UPIP, VSP V2 only). If the quantitative IC is set to NONE, which is the default, the IC concentration value is ignored. For VSP V2, the only valid quantitative IC selections are:
NONE
Enterobacteria phage T7
Escherichia virus T4
Escherichia Virus MS2
Armored RNA Quant Internal Process Control
Enter Internal Control (IC) concentration as an integer in the following scientific notation format: "#.## x 10^#". **An incorrect quantitative IC or incorrect IC concentration will result in inaccurate microorganism absolute quantification results.
Select the Project where the Analysis Output should be saved.
For version 1.1 and later, consensus FASTA files generated for each sample, virus, and reference sequence incorrectly contain soft-masked sequences instead of hard-masked sequences. To get hard-masked sequences, use {sample_name}.consensus_hard_masked_sequence.fa
or convert lowercase nucleotides to "N".
The Sample Composition bargraphs show the proportion of reads classified to six broad categories for of all samples in the analysis run: Targeted Microbial, Untargeted, Ambiguous, Unclassified, Low Complexity, and Targeted Internal Control (RPIP, UPIP, VSP V2 only).
The Summary Statistics table summarizes sample QC metrics for all samples in the analysis run. Further details on each metric can be found by hovering over each column header.
Individual sample results can be further explored by clicking on "Report" under each sample name in the panel on the left. There are four tabs in the Sample Report: Sample Quality Control, Microorganisms, Antimicrobial Resistance Markers, and User Options.
Version Information is a table with the application version, test type, and test version that were run. Running the latest version of the application is recommended.
Sample Composition is a bargraph showing the proportion of post-quality reads classified to six broad categories for the sample (RPIP, UPIP, VSP V2 only).
Read Classification is a dynamic plot that can be configured to show the following (RPIP, UPIP, VSP V2 only):
Targeted Microbial Reads - Relative (default): Bargraph of post-quality targeted microbial reads belonging to Viral, Bacterial, Fungal, Parasite and AMR categories, relative to post-quality targeted microbial reads only. Percentages are expected to sum to 100%. Hover over an individual bar to display the values.
Targeted Microbial Reads - Absolute: Bargraph of post-quality targeted microbial reads belonging to Viral, Bacterial, Fungal, Parasite and AMR categories for all post-quality reads in the sample overall. Hover over an individual bar to display the values.
Untargeted Reads - Relative: Bargraph of post-quality untargeted reads belonging to untargeted categories, relative to post-quality untargeted reads only. Percentages are expected to sum to 100%. Hover over an individual bar to display the values.
Untargeted Reads - Absolute: Bargraph of post-quality untargeted reads belonging to untargeted categories for all post-quality reads in the sample overall. Hover over an individual bar to display the values.
**Note that accurate sample composition and read classification results rely on selecting the correct enrichment panel. If you run an analysis that is not specific to the enrichment panel (e.g., VSP V2 analysis with VSP-enriched samples), reads from high background viruses that are not targeted by VSP probes (e.g., Measles virus) but that are targeted by VSP V2 probes will be reported as targeted viral reads.
Internal Controls is a table containing supported Internal Control options along with observed RPKM values (RPIP, UPIP, VSP V2 only).
QC Metrics is a table containing sample QC metrics. Dehosting refers to human reads only.
Microorganism results are summarized in tables, separated by type (Viruses, Bacteria, Fungi, Parasites). Each table includes whether the microorganism is predicted present in the sample, as well as various alignment metrics. Further details on each metric can be found by hovering over each column header. The best-match Reference Accession(s) are provided for all RPIP, RVOP/RVEK, VSP, and VSP V2 viruses in the Viruses table. To see all best-match Reference Accession(s), click on the three dots (...) in the table and scroll down the page.
Reference Coverage is a dynamic plot showing the coverage depth across the viral genome for detected RPIP, RVOP/RVEK, VSP, and VSP V2 viruses. Select a virus from the dropdown list to view the coverage plot. Segments are concatenated for segmented viruses, and the targeted regions of the viral genome are indicated for RPIP viruses.
Viral AMR (Variants) is a table with viral AMR variant results for Influenza A/B viruses (RPIP, RVOP/RVEK, VSP, and VSP V2 only)
Bacterial AMR (Genes) is a table witb bacterial AMR gene results (RPIP, UPIP only)
Bacterial AMR (Variants) is a table with bacterial AMR variant results (RPIP, UPIP only)
The User Options table summarizes user options selected during launch of the analysis.
A custom reference FASTA file containing one or more reference sequences is required to run the custom reference sequence analysis. In the FASTA file, sequence names must be unique and should not contain any spaces. If there is any space in the FASTA header, the part before the first space is assumed to be the sequence name. It is recommended to use only the following in sequence names: alphabets, numbers, underscore (_), hyphen (-), parentheses ((,)), and period (.). Otherwise, the sequence names may appear different in the output. An example custom reference FASTA file is provided in the link below.
To upload a custom reference FASTA file, go to the "Projects" tab and click on the folded paper icon (representing File) to reveal a dropdown menu. Click on "Upload" and select "Files". Within the upload page, select "Other" format for FASTA files, and upload the file as a Biosample. Within the DRAGEN Microbial Enrichment Plus app, under "Custom panel specification" use the "Custom reference FASTA for consensus generation" control to select the uploaded FASTA file.
Optionally, a custom reference BED file may also be provided. Sequence names must match between the FASTA file and BED file, and the same set of sequences must appear in both files. If there are multiple viruses, their names should be unique. For example, if there are multiple Influenza genomes, they should not be labeled with the same virus name in the 4th column.
The BED file controls how sequences are grouped and labeled in the output. If the custom reference FASTA file includes sequences from multiple segments of a viral genome, it is recommended to provide a BED file so that the segments are included under the results of that microorganism.
The BED file must be tab-delimited with at least 4 columns:
chrom: the sequence name as it appears in the FASTA
chromStart: start position (always set to 0)
chromEnd: end position (sequence length)
genomeName: name of the genome, target, or microorganism the sequence belongs to (e.g. Monkeypox virus clade II)
segmentName (optional): the name of the segment or gene (e.g. Segment 4 (HA)). Set to 'Full' if the sequence is the full genome
To upload a custom reference BED file, go to the "Projects" tab and click on the folded paper icon (representing File) to reveal a dropdown menu. Click on "Upload" and select "Files". Within the upload page, select "Other" format for BED files, and upload the file as a Biosample. Within the DRAGEN Microbial Enrichment Plus App, under "Custom panel specification" use the "Custom reference BED (optional)" dropdown to select the uploaded BED file.
For Custom Panel analyses, Pangolin is enabled and will run on custom reference sequences with at least 3% coverage that meet these naming conventions:
If only a FASTA file is provided, Pangolin will run on sequences that have a header containing either SARS-CoV-2 or NC_045512
If both a FASTA and BED file are provided, Pangolin will run on sequences where the first column (chrom) contains NC_045512 or the fourth column (genomeName) contains SARS-CoV-2
For Custom Panel analyses, Nextclade is disabled and will not be run. Do not enable Nextclade.
Enrichment panel | Template file |
---|
First, we recommend saving the provided template file with a new name
Do not add any new columns and do not delete any columns from the template file
Do not change or remove any text from the header row. **The "kmer_read_count" metric is only valid with the UPIP enrichment panel.
Rows with microorganism names that are not of interest can be deleted. However, the entire tiered reporting group for certain viruses must be included to preserve tiered reporting logic (if desired). Membership in a tiered reporting group means that a hierarchical relationship is pre-built into the database and the most granular tier level passing reporting thresholds is reported. For example, if Influenza B virus (B/Victoria/2/87-like)
or Influenza B virus (B/Yamagata/16/88-like)
are reported in a sample then the less granular Influenza B virus
reporting name will NOT be reported. See the "Has Tiered Reporting" and "Reporting Tier" columns of the "Microorganisms" table in the for RPIP, RVOP/RVEK, VSP, and VSP V2 to select and see which viruses are reported as part of a tiered reporting group.
Upload the microorganism reporting file to a BaseSpace Project. **It is only necessary to upload the file once.
Select the file by clicking on the "Dataset File(s)" option under the "User-defined specification" section.
See example below for 6 RPIP microorganism reporting names. Prediction logic can be specified on a microorganism-by-microorganism basis using multiple parameters and combinatorial logical expressions.
reporting_name | prediction_logic | coverage | median_depth | ani | aligned_read_count | rpkm | kmer_read_count |
---|
Enrichment panel |
---|
Abbreviation | Definition |
---|
Category | Test information |
---|
Abbreviation | Definition |
---|
Category | Test information |
---|
Read QC | Low-quality bases are trimmed from the ends of each read. After trimming, the read is discarded if fewer than 50% of its bases have a quality score greater or equal to q20, the read is shorter than 32 bp, or the read has 5 or more ambiguous bases. It is assumed that appropriate adapter trimming has already been performed. | Optional | X | X | X | X | X | X |
Dehosting | Human read removal | X | X | X | X | X | X |
Sample QC | Sample composition and enrichment factor calculations | Internal control required to calculate the enrichment factor | X | X | X |
Microorganism classification | Pre-alignment filtering step | Configurable sensitivity | X | X | X |
Microorganism detection | Reference alignment, consensus sequence generation, variant calling | X | X | X | X | X | X |
Microorganism quantification | Absolute copies/mL calculation | Quantitative internal control and concentration required | X | X | X |
Microorganism reporting thresholds | Proprietary algorithms or user-defined reporting logic | X | X | X | X | X |
Bacterial AMR marker analysis | Nucleotide and protein alignment, consensus sequence generation, variant calling and annotation | X | X |
Viral AMR marker analysis | Variant calling and annotation | X | X | X | X |
Viral clade and lineage prediction | Pangolin, Nextclade | X | X | X | X |
Result filters | User-specified filters applied | X | X | X | X | X |
Reporting - Analysis level | XLSX, HTML, ZIP | X | X | X | X | X | X |
Reporting - Sample level | JSON, HTML, FASTA (consensus sequences), VCF (viral variants) | X | X | X | X | X | X |
AMR | antimicrobial resistance |
CLSI | Clinical and Laboratory Standards Institute |
ESBL | extended spectrum beta-lactamase |
EUCAST | European Committee on Antimicrobial Susceptibility Testing |
mL | milliliter |
NGS | next-generation sequencing |
RPKM | targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads |
UPIP | Urinary Pathogen ID/AMR Panel |
RUO | For Research Use Only. Not for use in diagnostic procedures. |
URL | See https://www.illumina.com/ for additional information. |
Quantification - when a quantitative Internal Control {ic_name} and concentration {ic_concentration} is specified | UPIP data analysis using DRAGEN Microbial Enrichment Plus detects 35 viruses, 121 bacteria, 14 fungi, 4 parasites, and 4,371 AMR markers, unless filtered reporting options are selected, based on target enriched next-generation sequencing (NGS) of microorganism DNA sequences. Sequencing data are interpreted by the DRAGEN software platform and microorganisms that pass reporting thresholds are reported. Absolute quantification assumes use of {ic_name} as an Internal Control spiked at {ic_concentration} copies/mL of sample. Relative abundance is calculated based on absolute quantities and is expressed as proportion of absolute quantities within each pathogen class (i.e., bacteria, viruses, fungi, parasites). If RPKM for the Internal Control is zero, no absolute quantification is provided, and relative abundance is expressed as proportion of microorganism RPKM values within each pathogen class. |
Quantification - when a quantitative Internal Control is NOT specified | UPIP data analysis using DRAGEN Microbial Enrichment Plus detects 35 viruses, 121 bacteria, 14 fungi, 4 parasites, and 4,371 AMR markers, unless filtered reporting options are selected, based on target enriched next-generation sequencing (NGS) of microorganism DNA sequences. Sequencing data are interpreted by the DRAGEN software platform and microorganisms that pass reporting thresholds are reported. Relative abundance is expressed as proportion of microorganism RPKM values within each pathogen class (i.e., bacteria, viruses, fungi, parasites). Internal Control not specified; no absolute quantification provided. |
AMR - when "Report bacterial AMR markers only when an associated microorganism is reported" is selected | This test detects 4,371 antimicrobial resistance (AMR) markers and reports associations for 72 microorganisms, 185 antimicrobials, and 33 drug classes, unless filtered reporting options are selected. AMR markers are based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8). Detection of an AMR marker is reported if the AMR marker passes a minimum detection threshold and if one or more of the microorganisms associated with the AMR marker is also detected, in alignment with guidance provided by the College of American Pathologists (CAP) MIC.21855. However, reported AMR markers may originate from microorganisms that did not meet detection thresholds or microorganisms not targeted by the test. Association between microorganisms and AMR marker is based on scientific literature and the Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1) from McMaster University. 3,968 out of 4,371 AMR markers are associated with a microorganism targeted by UPIP. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR markers does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information. |
AMR - when "Report bacterial AMR markers only when an associated microorganism is reported" is NOT selected | This test detects 4,371 antimicrobial resistance (AMR) markers and reports associations for 72 microorganisms, 185 antimicrobials, and 33 drug classes. AMR markers are based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8). Association between microorganisms and AMR marker is based on scientific literature and the Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1) from McMaster University. Detection of an AMR marker is reported if the AMR marker passes a minimum detection threshold, regardless of associated microorganism detection. Reported AMR markers may originate from microorganisms that did not meet detection thresholds or microorganisms not targeted by the test. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR markers does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information. |
AMR | Linkage between AMR marker, antimicrobial, and drug class is based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8) from McMaster University, ResFinder (version 2.2.1), NCBI Reference Gene Catalog (version 2023-09-26.1), EUCAST expert rules on indicator agents (2019-2023), and CLSI Performance Standards for Antimicrobial Susceptibility Testing (M100 34th Edition). Not all antimicrobials and drug classes that are listed may be relevant. Detected AMR markers may also confer resistance to antimicrobials and drug classes that are not listed. |
AMR | A representative list of associated microorganisms known to harbor the detected or similar AMR markers, based on the Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1) from McMaster University, can be found in the Associated Microorganisms field. |
AMR | Mutations connected with a '+' form an epistatic group. Epistatic groups are two or more mutations that need to be present concurrently to confer the associated resistance. |
AMR | All intrinsic resistance described in CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100 34th Edition, Appendix B for detected microorganism(s) is reported. Additional comments regarding CLSI intrinsic resistance definitions may be reported in footnotes specific to the detected microorganism(s). Some intrinsic resistance is described with reference to drug classes rather than specific antimicrobials. Users may reference CLSI Glossary I (Part 1 and Part 2): Class and Subclass Designations and Generic Names for information on how CLSI categorizes antimicrobials and drug classes. |
AMR | Confidence of AMR marker detection is shown as High, Medium, or Low and is based on the available sequencing data. High confidence indicates that an AMR marker has 100% protein sequence coverage and 100% protein sequence percent identity (PID). Medium confidence indicates that an AMR marker has ≥90% protein sequence coverage and ≥90% protein sequence percent identity (PID). Low confidence indicates that an AMR marker has ≥60% protein sequence coverage and ≥80% protein sequence percent identity (PID). |
Phenotypic group | Targeted microorganisms are classified into three Phenotypic Groups based on general association with urinary tract infections, normal flora, colonization, or contamination from the environment or other sources. Phenotypic grouping DOES NOT INDICATE PATHOGENICITY IN A GIVEN CASE and results need to be interpreted in the context of all available information. Phenotypic Group 1: Microorganisms that are rarely associated with urinary tract infections and may frequently represent normal flora, colonizers, or contaminants. Phenotypic Group 2: Microorganisms that are infrequently associated with urinary tract infections and may frequently represent part of the normal flora, colonizers, or contaminants. Phenotypic Group 3: Microorganisms that are commonly associated with urinary tract infections but may also represent part of the normal flora, colonizers, or contaminants. |
Read classification | This test differentiates sequencing reads classified to microorganism and Internal Control regions that are targeted by capture probes (“Targeted Microbial” and “Targeted Internal Control”) from those that are not targeted (“Untargeted”), are low complexity (“Low Complexity”), cannot be unambiguously assigned to one category (“Ambiguous”), or cannot be classified with confidence (“Unclassified”). |
Limitations | Non-detected results do not rule out the presence of viruses, bacteria, fungi, parasites, and AMR markers. Contamination with microorganisms is possible during specimen collection, transport, and processing. Closely related microorganisms may be misidentified based on sequence homology to species present in the database. The identification of DNA sequences from a microorganism does not confirm that the identified microorganism is causing symptoms, is viable, or is infectious. Recombinant viral strains may not be reported or may be reported as one or more individual viruses. The Enterobacter cloacae complex may not be reported if targeted species members (Enterobacter cloacae, Enterobacter hormaechei, and Enterobacter cancerogenus) are not present. |
Limitations | The best matching allele is reported for each detected AMR gene family. If two or more alleles within the same AMR gene family are detected, only the allele with the higher confidence will be reported as the best match unless multiple alleles have a High confidence interpretation (100% protein sequence coverage and PID). In bacterial strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel. |
Limitations | Information provided by DRAGEN Microbial Enrichment Plus is based on scientific knowledge and has been curated; however, scientific knowledge evolves and information about associated microorganism and associated resistance may not always be complete and/or correct. Results should be interpreted in the context of all available information. Other sources of data may be required for confirmation. |
AMR | antimicrobial resistance |
CLSI | Clinical and Laboratory Standards Institute |
ESBL | extended spectrum beta-lactamase |
EUCAST | European Committee on Antimicrobial Susceptibility Testing |
mL | milliliter |
NAI | neuraminidase inhibitor |
NGS | next-generation sequencing |
PAI | polymerase acidic endonuclease inhibitor |
pangolin | phylogenetic assignment of named global outbreak lineages |
RPIP | Respiratory Pathogen ID/AMR Panel |
RPKM | targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads |
RUO | For Research Use Only. Not for use in diagnostic procedures. |
URL | See https://www.illumina.com/ for additional information. |
Quantification - when a quantitative Internal Control {ic_name} and concentration {ic_concentration} is specified | RPIP data analysis using DRAGEN Microbial Enrichment Plus detects 41 viruses, 187 bacteria, 53 fungi, and 4,079 AMR markers, unless filtered reporting options are selected, based on target enriched next-generation sequencing (NGS) of microorganism DNA and cDNA sequences. Sequencing data are interpreted by the DRAGEN software platform and microorganisms that pass detection thresholds are reported. Absolute quantification assumes use of {ic_name} as an Internal Control spiked at {ic_concentration} copies/mL of sample. Relative abundance is calculated based on absolute quantities and is expressed as proportion of absolute quantities within each pathogen class (i.e., bacteria, viruses, fungi). If RPKM for the Internal Control is zero, no absolute quantification is provided, and relative abundance is expressed as proportion of microorganism RPKM values within each pathogen class. |
Quantification - when a quantitative Internal Control is NOT specified | RPIP data analysis using DRAGEN Microbial Enrichment Plus detects 41 viruses, 187 bacteria, 53 fungi, and 4,079 AMR markers, unless filtered reporting options are selected, based on target enriched next-generation sequencing (NGS) of microorganism DNA and cDNA sequences. Sequencing data are interpreted by the DRAGEN software platform and microorganisms that pass detection thresholds are reported. Relative abundance is expressed as proportion of microorganism RPKM values within each pathogen class (i.e., bacteria, viruses, fungi). Internal Control not specified; no absolute quantification provided. |
AMR - when "Report bacterial AMR markers only when an associated microorganism is reported" is selected | This test detects 4,079 antimicrobial resistance (AMR) markers and reports associations for 99 microorganisms, 181 antimicrobials, and 35 drug classes, unless filtered reporting options are selected. Bacterial AMR markers are based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8) and viral AMR markers are based on World Health Organization (WHO) Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) Reduced Susceptibility Marker Tables (07 March 2023 version). Detection of an AMR marker is reported if the AMR marker passes a minimum detection threshold and if one or more of the microorganisms associated with the AMR marker is also detected, in alignment with guidance provided by the College of American Pathologists (CAP) MIC.21855. However, reported AMR markers may originate from microorganisms that did not meet detection thresholds or microorganisms not targeted by the test. Association between microorganisms and bacterial AMR marker is based on scientific literature and the Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1) from McMaster University. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR markers does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information. |
AMR - when "Report bacterial AMR markers only when an associated microorganism is reported" is NOT selected | This test detects 4,079 antimicrobial resistance (AMR) markers and reports associations for 99 microorganisms, 181 antimicrobials, and 35 drug classes. Bacterial AMR markers are based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8) and viral AMR markers are based on World Health Organization (WHO) Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) Reduced Susceptibility Marker Tables (07 March 2023 version). Association between microorganisms and bacterial AMR marker is based on scientific literature and the Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1) from McMaster University. Detection of a bacterial AMR marker is reported if the marker passes a minimum detection threshold, regardless of associated microorganism detection. Reported AMR markers may originate from microorganisms that did not meet detection thresholds or microorganisms not targeted by the test. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR markers does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information. |
AMR | Linkage between bacterial AMR marker, antimicrobial, and drug class is based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8) from McMaster University, ResFinder (version 2.2.1), NCBI Reference Gene Catalog (version 2023-09-26.1), EUCAST expert rules on indicator agents (2019-2023), and CLSI Performance Standards for Antimicrobial Susceptibility Testing (M100 34th Edition). Linkage between viral AMR marker, antimicrobial, and drug class is based on the publications provided in the JSON report - see PubMed IDs (pmids) field. Not all antimicrobials and drug classes that are listed may be relevant. Detected AMR markers may also confer resistance to antimicrobials and drug classes that are not listed. |
AMR | A representative list of associated microorganisms known to harbor the detected or similar bacterial AMR markers, based on the Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1) from McMaster University, can be found in the Associated Microorganisms field. |
AMR | Mutations connected with a '+' form an epistatic group. Epistatic groups are two or more mutations that need to be present concurrently to confer the associated resistance. |
AMR | All intrinsic resistance described in CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100 34th Edition, Appendix B for detected microorganism(s) is reported. Additional comments regarding CLSI intrinsic resistance definitions may be reported in footnotes specific to the detected microorganism(s). Some intrinsic resistance is described with reference to drug classes rather than specific antimicrobials. Users may reference CLSI Glossary I (Part 1 and Part 2): Class and Subclass Designations and Generic Names for information on how CLSI categorizes antimicrobials and drug classes. |
AMR | Confidence of bacterial AMR marker detection is shown as High, Medium, or Low and is based on the available sequencing data. High confidence indicates that a bacterial AMR marker has 100% protein sequence coverage and 100% protein sequence percent identity (PID). Medium confidence indicates that a bacterial AMR marker has ≥90% protein sequence coverage and ≥90% protein sequence percent identity (PID). Low confidence indicates that a bacterial AMR marker has ≥60% protein sequence coverage and ≥80% protein sequence percent identity (PID). |
Phenotypic group | Targeted microorganisms are classified into three Phenotypic Groups based on general association with normal flora, colonization, or contamination from the environment or other sources, as well as based on general association with disease. Phenotypic grouping DOES NOT INDICATE PATHOGENICITY IN A GIVEN CASE and results need to be interpreted in the context of all available information. Phenotypic Group 1: Microorganisms that are frequently considered part of the normal flora, colonizers, or contaminants but may be associated with disease in certain settings. Phenotypic Group 2: Microorganisms that may represent normal flora, colonizers, or contaminants but that are frequently associated with disease. Phenotypic Group 3: Microorganisms that are not generally considered part of the normal flora, colonizers, or contaminants and are generally considered to be associated with disease. |
Pango lineage | The most likely Pango (phylogenetic assignment of named global outbreak) lineage is assigned to the majority consensus SARS-CoV-2 genome sequence using pangolin 4.3.1 (Áine O'Toole & Emily Scher et al. 2021 Virus Evolution DOI:10.1093/ve/veab064). |
Read classification | This test differentiates sequencing reads classified to microorganism and Internal Control regions that are targeted by capture probes (“Targeted Microbial” and “Targeted Internal Control”) from those that are not targeted (“Untargeted”), are low complexity (“Low Complexity”), cannot be unambiguously assigned to one category (“Ambiguous”), or cannot be classified with confidence (“Unclassified”). |
Limitations | Non-detected results do not rule out the presence of viruses, bacteria, fungi, and AMR markers. Contamination with microorganisms is possible during specimen collection, transport, and processing. Closely related microorganisms may be misidentified based on sequence homology to species present in the database. The identification of cDNA or DNA sequences from a microorganism does not confirm that the identified microorganism is causing symptoms, is viable, or is infectious. Recombinant viral strains may not be reported or may be reported as one or more individual viruses. Should one or more individual viruses be reported for a recombinant viral strain, antiviral resistance results may be inaccurate. |
Limitations | The best matching allele is reported for each detected bacterial AMR gene family. If two or more alleles within the same bacterial AMR gene family are detected, only the allele with the higher confidence will be reported as the best match unless multiple alleles have a High confidence interpretation (100% coverage and PID). In strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel. |
Limitations | Information provided by DRAGEN Microbial Enrichment Plus is based on scientific knowledge and has been curated; however, scientific knowledge evolves and information about associated microorganism and associated resistance may not always be complete and/or correct. Results should be interpreted in the context of all available information. Other sources of data may be required for confirmation. |
Samplename.Panelname.report.json
json
Comprehensive report file. See Report JSON format for further details
Samplename.Panelname.report.html
html
Visual report file. See Understanding the BaseSpace HTML reports for further details
Samplename.Panelname.viral_variants.vcf
vcf
Viral variant call file describing variant calls between viral consensus genome (or segment) sequences and best-match reference sequences (all RVOP/RVEK, VSP, and VSP V2 viruses, RPIP: SARS-CoV-2 & FluA/B/C only)
Samplename.Panelname.viral_genomes_consensus.fa
fasta
Viral genome (or segment) nucleotide consensus sequence(s) for all viruses reported in the sample (RPIP, RVOP/RVEK, VSP, VSP V2 only)
Samplename.Panelname.viral_targets_consensus.fa
fasta
Viral targeted region nucleotide consensus sequence(s) for all viruses reported in the sample (RPIP only)
Samplename.Panelname.bacterial_amr_nucleotide_consensus.fa
fasta
Bacterial AMR gene nucleotide consensus sequence(s) for all bacterial AMR markers reported in the sample (RPIP, UPIP only)
Samplename.Panelname.bacterial_amr_protein_consensus.fa
fasta
Bacterial AMR gene protein consensus sequence(s) for all bacterial AMR markers reported in the sample (RPIP, UPIP only)
viral_consensus_genomes
Dataset
Directory containing viral genome (or segment) nucleotide consensus sequence(s) per virus reported in the sample (RPIP, RVOP/RVEK, VSP, VSP V2 only)
AnalysisIDnumber.Panelname.results.zip
zip
Compressed file containing all output files for single-click download
AnalysisIDnumber.Panelname.report.xlsx
xlsx
Aggregate Excel report file that summarizes results for all samples across 4 tabs: Samples, Microorganisms, AMR, and Variants. See below for further details
report.html
html
Visual report file. See Understanding the BaseSpace HTML reports for further details
Acinetobacter baumannii | default |
Cryptococcus neoformans | coverage | 0.3 |
Escherichia coli | aligned_read_count | 200 |
Human adenovirus E | (coverage AND median_depth) OR (aligned_read_count AND ani) | 0.1 | 1 | 0.95 | 100 |
Human bocavirus 1 (HBoV1) | rpkm OR (ani AND coverage) OR median_depth | 0.2 | 5 | 0.9 | 5 |
Klebsiella pneumoniae | default AND coverage | 0.5 |
Abbreviation | Definition |
---|---|
Category | Test information |
---|---|
The DRAGEN Microbial Enrichment Plus app outputs a comprehensive sample-level report.json
file containing general metadata, version information, sample QC, microorganism, and AMR marker results, as well as detailed test information. The additional convenience file formats generated by the DRAGEN Microbial Enrichment Plus app do not contain novel content.
(*) indicates results generated by the application layer as opposed to the DRAGEN secondary analysis pipeline
Top-Level Node
The top-level section of the report JSON contains general metadata and version information.
Field | Description |
---|---|
.qcReport.sampleQc Node
This section contains information about sample quality control (QC). The fields are relative to .qcReport.sampleQc
.qcReport.enrichmentFactor Node
This section contains information about the enrichment factor calculation and is relevant to RPIP, UPIP, and VSP V2 only. Detection of an appropriate Internal Control is required. The fields are relative to .qcReport.enrichmentFactor
.qcReport.sampleComposition Node
This section contains information about the composition of the sample and is provided for RPIP, UPIP, and VSP V2 only. The fields are relative to .qcReport.sampleComposition
.qcReport.internalControls Node
This section contains information about internal control detection and is relevant to RPIP, UPIP, and VSP V2 only. The value of the .qcReport.internalControls
field is an array of objects containing name and RPKM information for each Internal Control. See the code block below for an example:
.userOptions Node
This section gives information about analysis options specified by the user. The fields are relative to .userOptions
.targetReport.microorganisms[] Node
The value of the .targetReport.microorganisms[]
field is an array of objects containing information about detected microorganisms. The following table describes one .targetReport.microorganisms[]
object. The fields are relative to .targetReport.microorganisms[]
.targetReport.microorganisms[].predictionInformation[].relatedMicroorganisms[] Node
The value of the .targetReport.microorganisms[].predictionInformation[].relatedMicroorganisms[]
field is an array of objects containing information about genetically related microorganisms. The following table describes one .targetReport.microorganisms[].predictionInformation[].relatedMicroorganisms[]
object. The fields are relative to .targetReport.microorganisms[].predictionInformation[].relatedMicroorganisms[]
.targetReport.microorganisms[].variants[] Node
The value of the .targetReport.microorganisms[].variants[]
field is an array of objects containing information about viral variants for all RVOP/RVEK, VSP, and VSP V2 viruses, RPIP: SARS-CoV-2 & FluA/B/C only. The following table describes one .targetReport.microorganisms[].variants[]
object. The fields are relative to .targetReport.microorganisms[].variants[]
.targetReport.microorganisms[].pangoLineage[] Node
The value of the .targetReport.microorganisms[].pangoLineage[]
field is an array of objects containing information about SARS-CoV-2 Pango lineage prediction results. The following table describes one .targetReport.microorganisms[].pangoLineage[]
object. The fields are relative to .targetReport.microorganisms[].pangoLineage[]
.
.targetReport.microorganisms[].nextclade[] Node
The value of the .targetReport.microorganisms[].nextclade[]
field is an array of objects containing information about viral clade assignment results for applicable viruses. The following table describes one .targetReport.microorganisms[].nextclade[]
object. The fields are relative to .targetReport.microorganisms[].nextclade[]
.
.targetReport.amrMarkers[] Node
The value of the .targetReport.amrMarkers[]
field is an array of objects containing information about detected bacterial AMR markers. The following table describes one .targetReport.amrMarkers[]
object. The fields are relative to .targetReport.amrMarkers[]
.targetReport.amrMarkers[].variants[] Node
The value of the .targetReport.amrMarkers[].variants[]
field is an array of objects containing information about variants for bacterial AMR markers with "protein variant" or "rRNA variant" model types. The following table describes one .targetReport.amrMarkers[].variants[]
object. The fields are relative to .targetReport.amrMarkers[].variants[]
.targetReport.customReferences[] Node
This section contains information about custom reference detection results and is only present for custom database analyses. When only a custom reference FASTA file is provided (no BED file), each .targetReport.customReferences[]
object contains information for a single reference sequence. When both a FASTA and BED file are provided, each .targetReport.customReferences[]
object contains information for a single genome/microorganism, which can be a collection of one or more reference sequences. The fields are relative to .targetReport.customReferences[]
.targetReport.customReferences[].consensusSequences[] Node
The value of the .targetReport.customReferences[].consensusSequences[]
field is an array of objects containing majority consensus sequence information for a single custom reference sequence. When only a FASTA file is provided (no BED file), there will be only one object in the array. When both a FASTA and BED file are provided, there may be more than one object in the array. The fields are relative to .targetReport.customReferences[].consensusSequences[]
.targetReport.customReferences[].variants[] Node
The value of the .targetReport.customReferences[].variants[]
field is an array of objects containing information about a single detected variant. The fields are relative to .targetReport.customReferences[].variants[]
.targetReport.customReferences[].pangoLineage[] Node
The value of the .targetReport.customReferences[].pangoLineage[]
field is an array of objects containing information about SARS-CoV-2 Pango lineage prediction results. The following table describes one .targetReport.customReferences[].pangoLineage[]
object. The fields are relative to .targetReport.customReferences[].pangoLineage[]
.additionalInformation[] Node
The value of the .additionalInformation[]
field is an array of objects containing additional information about the test and data analysis solution. The fields are relative to .additionalInformation[]
Abbreviation | Definition |
---|
Category | Test information |
---|
Application note:
Application note:
Technical note:
Genomics Research Hub (GRH) article:
Data sheet:
UPIP ID Week Scientific Poster:
Application note:
Application note:
Application note:
Abbreviation | Definition |
---|
Category | Test information |
---|
Abbreviation | Definition |
---|
Category | Test information |
---|
A: RPIP, UPIP, RVOP/RVEK, VSP, VSP V2, and Custom infectious disease and microbiology enrichment panels. To analyze the Pan-Coronavirus (Pan-CoV) panel, a custom coronavirus reference sequence database may be specified. The DME+ app is not intended for use with non-infectious disease enrichment panels (such as human exome).
A: The only infectious disease and microbiology enrichment panel without a pre-set DME+ database is the Pan-CoV panel. To analyze Pan-CoV enriched data with the DME+ app, select "Custom Panel" under the "Enrichment Panel" drop-down list and specify a custom coronavirus reference sequence database. Alternatively, we recommend using the DRAGEN Targeted Microbial app.
A: A Basic Basespace Sequence Hub (BSSH) user account is required to access the DME+ app. However, there is no subscription cost for a Basic BSSH account and no compute cost to run the DME+ app. A Basic BSSH account provides 1 TB of free storage. Additional storage may require iCredits.
A: Upload these files to a BSSH project before launching the DME+ app. It will then be possible to select these files in the "Select Dataset File(s)" browser in the app. Please see and reach out to techsupport@illumina.com with any unresolved upload issues.
A: See the "Virus Types Captured" column of the "Microorganisms" table in the .
A: The VSP V2 viral genome sourcing approach aimed at being as inclusive and comprehensive as possible for the 200 targeted human viruses. All viral genomes passing quality filters available as of June 2023 were included in the design, including recombinant and vaccine strains.
A: While there are many possible reasons, one of the most common causes is that the custom database was not formatted correctly. Below are requirements for the custom reference FASTA and (optional) BED file:
Do not exceed the file size limitation: 10 million bases
Do not include duplicate entries
Do not use spaces in the file name; instead use an underscore "_"
File extension must be .fasta or .fa for custom reference FASTA file and .bed for custom reference BED file
If providing a custom reference BED file, the names in the first column of the BED file (chrom) must match the names that appear in the FASTA file (text after > and before the first whitespace character).
A: If enabled, low-quality bases are trimmed from the ends of each read. After trimming, the read is discarded if fewer than 50% of its bases have a quality score greater or equal to q20, the read is shorter than 32 bp, or the read has 5 or more ambiguous bases. It is assumed that appropriate adapter trimming has already been performed.
A: This setting is used as a pre-alignment filtering step for all viral whole-genome sequencing (WGS) panels. The default setting of 5 means that if less than 5 reads classify to the set of reference sequences belonging to a given virus, that virus will not be reported. On the other hand, if 5 or more reads classify to the set of reference sequences belonging to a given virus, read alignment will proceed and alignment-based thresholds will be used to determine whether that virus is reported. The read classification sensitivity can be set as low as 1 or as high as 1000. Lowering the read classification sensitivity threshold below 5 may significantly increase computational run time and is not recommended for most use cases.
A: Pangolin is currently enabled for all enrichment panels except UPIP. For Custom Panel analyses, Pangolin is enabled and will run on custom reference sequences with at least 3% coverage that meet these naming conventions:
If only a FASTA file is provided, Pangolin will run on sequences that have a header containing either SARS-CoV-2 or NC_045512
If both a FASTA and BED file are provided, Pangolin will run on sequences where the first column (chrom) contains NC_045512 or the fourth column (genomeName) contains SARS-CoV-2
A: When enabled, a Nextclade analysis using the specified dataset(s) is run for the following microorganisms, as applicable:
A: The RPIP, UPIP, and VSP V2 enrichment panels contain probes targeting commercially available Internal Controls. See the table below for Internal Control options compatible with RPIP, UPIP, and VSP V2. It is recommended to spike each sample prior to extraction with Enterobacteria phage T7 at 1.21 x 10^7 copies/mL of sample.
*Quantitative Internal Control concentration must be provided
A: See the table below. Consensus sequence bases without aligned read support are indicated by "N" bases.
A: To evaluate microorganism absolute quantification results, it is recommended to perform experiments using the relevant sample type and full sequencing workflow (including extraction) and to compare results obtained from the DME+ app with those from digital droplet PCR (ddPCR) and/or quantitative PCR (qPCR) assays. A per-microorganism absolute quantification correction factor can be applied to DME+ results as needed.
A: Yes. Not all antimicrobials and drug classes that are listed may be relevant. Detected AMR markers may also confer resistance to antimicrobials and drug classes that are not listed. Linkage between bacterial AMR marker, antimicrobial, and drug class is based on the Comprehensive Antibiotic Research Database (CARD, version 3.2.8) from McMaster University, ResFinder (version 2.2.1), NCBI Reference Gene Catalog (version 2023-09-26.1), EUCAST expert rules on indicator agents (2019-2023), and CLSI Performance Standards for Antimicrobial Susceptibility Testing (M100 34th Edition). Linkage between viral AMR marker, antimicrobial, and drug class is based on the publications provided in the JSON report - see the PubMed IDs (pmids) field.
A: For complex samples or samples with the majority of nucleic acid being host/untargeted, while 100-1000X more targeted reads and sensitivity over a shotgun/pre-enriched library is expected, typically targeted reads will still only represent a minority of the overall sequencing reads. Notably, RPIP, UPIP, and VSP V2 support various Internal Control options that can be spiked into samples prior to extraction to enable automated calculation of an enrichment factor sample QC metric.
A: The % Targeted Microbial Reads is calculated using a kmer-based classification approach that is intended to give a quick, high-level overview of sample composition. The Aligned Read Count values for microorganisms are calculated in a separate pipeline step using microorganism-specific reference sequence alignment as opposed to broad, categorical, kmer-based classification. Reads that were unclassified or that were classified as low-complexity or ambiguous may actually align to reference sequences. It is also possible for a read to align to a reference sequence of more than one microorganism, for example in a conserved region.
A: FASTQ files previously run through other apps can be re-analyzed using the DME+ app. Results from other apps may not be identical to results from the DME+ app, most notably because of the expanded databases used in DME+.
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Field | Description |
---|---|
Data sheet:
Data sheet:
A: The full viral genome is targeted for all RVOP/RVEK, VSP, and VSP V2 viruses. For RPIP viruses, see the "Percent Genome Targeted" column of the "Microorganisms" table in the . No more than ~1% of bacterial, fungal, and parasitic genomes are targeted by RPIP or UPIP.
See for further details.
A: Ensure that the correct microorganism reporting file was uploaded and used. We recommend saving the updated microorganism reporting file with a new name. Rows with microorganism names that are not of interest can be deleted, but do not add any new columns or delete any columns from the provided template. Similarly, do not change or remove any text from the header row. Also, please note that the "kmer_read_count" metric is only valid with the UPIP panel. See for further details.
Microorganism | Nextclade Dataset | Type of Nextclade Dataset |
---|
Internal Control | RPIP | UPIP | VSP V2 | Process control | Enrichment factor calculation | Microorganism absolute quantification* | Notes |
---|
Setting | Value |
---|
A: Not necessarily. The microbe of interest may be present in the sample, but the DME+ app may not have reported it because the detection metrics fell below the default reporting thresholds. If it is suspected that this may be the case, select the "Report microorganisms and/or AMR markers that are below threshold" option. A user-defined microorganism reporting file can also be specified on a microorganism-by-microorganism basis using multiple parameters should more sensitive reporting be required for a given use case. See for further details.
A: Multiple parameters are used to determine whether the sequencing data for a given microorganism is sufficient for a positive call. These may include the horizontal coverage, median read depth, normalized read count, average nucleotide identity, etc of the microorganism and/or other genetically related microorganisms. The default reporting thresholds are different for different microorganisms, as microorganisms with close genetic neighbors generally require more stringent reporting thresholds than genetically distinct microorganisms. As with most tests and prediction algorithms, the default reporting thresholds are intended to balance the trade-off between analytical sensitivity and specificity. Should a given use case require more sensitive or specific reporting, a user-defined microorganism reporting file can be specified on a microorganism-by-microorganism basis using multiple parameters. See for further details. Additionally, the "Report microorganisms and/or AMR markers that are below threshold" option can be enabled.
A: Mathematically, any result with a horizontal coverage of <50% will have a median depth of 0 (50% or more of the nucleotide positions have a depth of 0). Low coverage results could represent true low positives (the most likely reason) or non-specific results, contamination, etc. If maximum confidence is required for a given use case, stricter microorganism reporting thresholds can be specified on a microorganism-by-microorganism basis using multiple parameters. See for further details.
A: See the "Has Tiered Reporting" and "Reporting Tier" columns of the "Microorganisms" table in the for RPIP, RVOP/RVEK, VSP, and VSP V2 to select and see which viruses are reported as part of a tiered reporting group. Membership in a tiered reporting group means that a hierarchical relationship is pre-built into the database and the most granular tier level passing reporting thresholds is reported. For example, if Influenza B virus (B/Victoria/2/87-like)
or Influenza B virus (B/Yamagata/16/88-like)
are reported in a sample then the less granular Influenza B virus
reporting name will NOT be reported. Tiered reporting group membership is especially relevant when specifying a user-defined microorganism reporting file as including the entire tiered reporting group is necessary to preserve tiered reporting logic.
A: See the "Has Tiered Reporting" and "Lineage/Clade Prediction" columns of the "Microorganisms" table in the for RPIP, RVOP/RVEK, VSP, and VSP V2. Consensus sequence and best match reference accession are also provided for RPIP, RVOP/RVEK, VSP, and VSP V2 viruses. Subtype information may be possible to infer from the consensus sequence (e.g. by Blast) or from the best match reference accession (if annotated in NCBI). Consensus sequence can also be used as input to downstream viral typing tools.
A: Viral genomes are orders of magnitude smaller and thus computationally much "cheaper" to align to than bacterial, fungal, and parasitic genomes. In the case of RVOP/RVEK, VSP, and VSP V2, the full viral genome is targeted for all viruses. For RPIP viruses, see the "Percent Genome Targeted" column of the "Microorganisms" table in the . While not visualized in the HTML report at this time, the DME+ does contain coverage depth vector information for all microorganism targeted regions (viruses, bacteria, fungi, and parasites). See: .targetReport.microorganisms[].condensedDepthVector[]
, which is the read depth across the targeted microorganism reference sequences, condensed (if needed) into 256 bins.
AMR
antimicrobial resistance
mL
milliliter
NAI
neuraminidase inhibitor
NGS
next-generation sequencing
PAI
polymerase acidic endonuclease inhibitor
pangolin
phylogenetic assignment of named global outbreak lineages
RPKM
targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads
VSP
Viral Surveillance Panel
RUO
For Research Use Only. Not for use in diagnostic procedures.
URL
See https://www.illumina.com/ for additional information.
Quantification
VSP data analysis using DRAGEN Microbial Enrichment Plus detects 149 viruses and 238 AMR markers based on target enriched next-generation sequencing (NGS) of viral DNA and cDNA sequences. Sequencing data are interpreted by the DRAGEN software platform and viruses that pass detection thresholds are reported. Relative abundance is expressed as proportion of RPKM values.
AMR
This test detects 238 antimicrobial resistance (AMR) markers associated with resistance to Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) in Influenza A virus (H1N1pdm09), Influenza A virus (H1N1), Influenza A virus (H5N1), Influenza A virus (H3N2), Influenza A virus (H3N2; swine-like), Influenza A virus (H7N9), and Influenza B virus. AMR markers and drug associations are based on the World Health Organization (WHO) Influenza virus NAI and PAI Reduced Susceptibility Marker Tables (07 March 2023 version). Detection of an AMR marker is reported if the marker passes a minimum detection threshold and if the Influenza virus associated with the marker is also detected. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR variants does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information.
AMR
Mutations connected with a '+' form an epistatic group. Epistatic groups are two or more mutations that need to be present concurrently to confer the associated resistance.
Pango lineage
The most likely Pango (phylogenetic assignment of named global outbreak) lineage is assigned to the majority consensus SARS-CoV-2 genome sequence using pangolin 4.3.1 (Áine O'Toole & Emily Scher et al. 2021 Virus Evolution DOI:10.1093/ve/veab064).
Limitations
Non-detected results do not rule out the presence of viruses and AMR markers. Contamination is possible during specimen collection, transport, and processing. Closely related viruses may be misidentified based on sequence homology to viruses present in the database. The identification of cDNA or DNA sequences from a virus does not confirm that the identified virus is causing symptoms, is viable, or is infectious. Recombinant viral strains may not be reported or may be reported as one or more individual viruses. Should one or more individual viruses be reported for a recombinant viral strain, antiviral resistance results may be inaccurate. In viral strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel.
Limitations
Information provided by DRAGEN Microbial Enrichment Plus is based on scientific knowledge and has been curated; however, scientific knowledge evolves and reported information may not always be complete and/or correct. Results should be interpreted in the context of all available information. Other sources of data may be required for confirmation.
.accession
Identifier used for the sample
.deploymentEnvironment
Environment in which the results were produced
.batchId
Identifier used for the batch of samples processed together
.analysisId
Identifier used for the analysis
.runId
Identifier used for the sequencing run
.controlFlag
Indicates whether the sample is a control. It is set to “POS” if the substring “PosCon” is found in the sample name, “NEG” if the substring “NegCon” is found, or “BLANK” if the substring “controlBlk” is found. Otherwise, it is set to “-”
.dragenVersion
DRAGEN release version
.analysisPipelineVersion
Analysis Pipeline release version
.testType
Type of test panel ("RPIP", "UPIP", "RVOP", "VSPv1", "VSPv2", "Custom")
.testVersion
Test panel release version
.testName
Full name of test panel
.testUse
Test use. "For Research Use Only. Not for use in diagnostic procedures"
.reportTime
Date and time the report was generated
.warnings
List of warnings encountered during the analysis
.errors
List of errors encountered during the analysis
.results*
High level result: “One or more potential pathogens predicted” or ”No potential pathogens predicted”
.appVersion*
DRAGEN Microbial Enrichment plus application release version
.totalRawBases
Number of base pairs in sample before read QC processing
.totalRawReads
Number of reads in sample before read QC processing
.uniqueReads
Number of distinct reads in sample before read QC processing
.uniqueReadsProportion
Proportion of distinct reads in sample before read QC processing
.preQualityMeanReadLength
Average read length before read QC processing
.postQualityMeanReadLength
Average read length after read QC processing
.postQualityReads
Number of reads in sample after read QC processing, inclusive of any duplicate reads
.postQualityReadsProportion
Proportion of post-quality reads in sample relative to total raw reads
.removedInDehostingReads
Number of host reads in sample removed during dehosting (host = human)
.removedInDehostingReadsProportion
Proportion of host reads in sample removed relative to total raw reads (host = human)
.entropy
Shannon entropy of the counts of 5-mers in the reads after read QC processing, which is a measure of randomness
.gContent
Proportion of guanine (G) base calls in reads after read QC processing
.libraryQScore
Quality score of the library after read QC processing
.value
Enrichment factor value reflecting how well targeted regions were enriched
.category
Enrichment factor category: "poor", "fair", "good", or "not calculated"
.readClassification
Proportion of post-quality reads classified to the following categories:
.readClassification.targetedMicrobial
Targeted microbial
.readClassification.targetedInternalControl
Targeted Internal Control
.readClassification.untargeted
Untargeted
.readClassification.ambiguous
More than one category
.readClassification.unclassified
No category
.readClassification.lowComplexity
Low complexity
.targetedMicrobial
Proportion of post-quality targeted microbial reads classified to the following sub-categories:
.targetedMicrobial.viral
Viral targeted
.targetedMicrobial.bacterial
Bacterial targeted
.targetedMicrobial.fungal
Fungal targeted
.targetedMicrobial.parasitic
Parasitic targeted
.targetedMicrobial.bacterialAmr
Bacterial AMR targeted
.untargeted
Proportion of post-quality untargeted reads classified to the following sub-categories:
.untargeted.viral
Viral untargeted
.untargeted.bacterial
Bacterial untargeted
.untargeted.fungal
Fungal untargeted
.untargeted.parasitic
Parasitic untargeted
.untargeted.bacterialAmr
Bacterial AMR untargeted
.untargeted.internalControl
Internal Control untargeted
.untargeted.human
Human untargeted
.viral
Proportion of post-quality viral reads classified to the following categories:
.viral.targeted
Viral targeted
.viral.untargeted
Viral untargeted
.viral.untargetedSubcategories
Proportion of post-quality viral untargeted reads classified to the following sub-categories:
.viral.untargetedSubcategories.panel
Viral panel members
.viral.untargetedSubcategories.phage
Viral phage
.viral.untargetedSubcategories.other
Viral other (not a panel member or phage)
.bacterial
Proportion of post-quality bacterial reads classified to the following categories:
.bacterial.targeted
Bacterial targeted
.bacterial.untargeted
Bacterial untargeted
.bacterial.untargetedSubcategories
Proportion of post-quality bacterial untargeted reads classified to the following sub-categories:
.bacterial.untargetedSubcategories.panel
Bacterial panel members
.bacterial.untargetedSubcategories.ribosomalDna
Bacterial ribosomal DNA (16S)
.bacterial.untargetedSubcategories.plasmid
Bacterial plasmids
.bacterial.untargetedSubcategories.other
Bacterial other (not a panel member, ribosomal DNA, or plasmid)
.fungal
Proportion of post-quality fungal reads classified to the following categories:
.fungal.targeted
Fungal targeted
.fungal.untargeted
Fungal untargeted
.fungal.untargetedSubcategories
Proportion of post-quality fungal untargeted reads classified to the following sub-categories:
.fungal.untargetedSubcategories.panel
Fungal panel members
.fungal.untargetedSubcategories.ribosomalDna
Fungal ribosomal DNA (18S)
.fungal.untargetedSubcategories.other
Fungal other (not a panel member or ribosomal DNA)
.parasitic
Proportion of post-quality parasitic reads classified to the following categories:
.parasitic.targeted
Parasitic targeted
.parasitic.untargeted
Parasitic untargeted
.parasitic.untargetedSubcategories
Proportion of post-quality parasitic untargeted reads classified to the following sub-categories:
.parasitic.untargetedSubcategories.panel
Parasitic panel members
.parasitic.untargetedSubcategories.ribosomalDna
Parasitic ribosomal DNA (18S)
.parasitic.untargetedSubcategories.other
Parasitic other (not a panel member or ribosomal DNA)
.human
Proportion of post-quality human reads classified to the following categories:
.human.untargeted
Human untargeted
.human.untargetedSubcategories
Proportion of post-quality human untargeted reads classified to the following sub-categories:
.human.untargetedSubcategories.ribosomalDna
Human ribosomal DNA
.human.untargetedSubcategories.codingSequence
Human coding sequence
.human.untargetedSubcategories.other
Human other (not ribosomal DNA or coding sequence)
.internalControl
Proportion of post-quality Internal Control reads classified to the following categories:
.internalControl.targeted
Internal Control targeted
.internalControl.untargeted
Internal Control untargeted
.microbialAndInternalControl
Proportion of post-quality Microbial and Internal Control reads classified to the following categories:
.microbialAndInternalControl.targeted
Microbial and Internal Control targeted
.microbialAndInternalControl.untargeted
Microbial and Internal Control untargeted
.bacterialAmr
Proportion of post-quality bacterial AMR reads classified to the following categories:
.bacterialAmr.targeted
Bacterial AMR targeted
.bacterialAmr.untargeted
Bacterial AMR untargeted
.quantitativeInternalControlName
Quantitative Internal Control used for microorganism absolute quantification (recommendation: Enterobacteria phage T7)
.quantitativeInternalControlConcentration
Quantitative Internal Control concentration (recommendation: 1.21 x 10^7 copies/mL of sample)
.readQcEnabled
Boolean indicating if read QC (trimming and filtering based on quality and read length) is enabled
.readClassificationSensitivity
(RVOP/RVEK, VSP, VSP V2 only) Sensitivity threshold for classifying reads. Determines whether alignment should proceed for a microorganism and/or reference sequence. Value is an integer with a valid range of 1 to 1000, inclusive
.customPanelFastaFile
(Custom Panel only) Name of the custom reference FASTA file
.customPanelBedFile
(Custom Panel only) Name of the custom reference BED file
.belowThresholdEnabled*
Boolean indicating if microorganisms and/or AMR markers below detection thresholds are reported
.bacterialAmrMarkersOnly*
(RPIP, UPIP only) Boolean indicating if only bacterial AMR markers are reported
.bacterialAmrMarkerMicroorganismRequired*
(RPIP, UPIP only) Boolean indicating if bacterial AMR markers are reported only when an associated microorganism is reported
.preDefinedMicroorganismReportingList*
(RPIP, UPIP only) Pre-defined microorganism reporting list, if specified
.userDefinedMicroorganismReportingListUsed*
Boolean indicating if a user-defined microorganism reporting file is specified
.userDefinedMicroorganismReportingListFile*
Name of the user-defined microorganism reporting file, if specified
.providedAnalysisName*
User-provided analysis name
.class
Microorganism class ("viral", "bacterial", "fungal", "parasite")
.name
Name of microorganism
.coverage
Proportion of targeted microorganism reference sequence bases that appear in sample sequencing reads
.ani
Average nucleotide identity of consensus sequence to targeted microorganism reference sequences
.medianDepth
Median depth of sample sequencing reads aligned to targeted microorganism reference sequences, indicating the median number of times each targeted microorganism reference sequence base appears in sample sequencing reads
.condensedDepthVector
Read depth across the targeted microorganism reference sequences, condensed to 256 bins
.rpkm
Normalized representation of the number of sample sequencing reads aligned to targeted microorganism reference sequences (targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads)
.alignedReadCount
Number of sample sequencing reads that aligned to targeted microorganism reference sequences
.kmerReadCount
(UPIP only) Number of sample sequencing reads classified to targeted microorganism reference sequences
.absoluteQuantityRatio
Numerical absolute quantification value. Quantitative internal control required for calculation
.absoluteQuantityRatioFormatted
Formatted absolute quantification value with units. Quantitative internal control required for calculation
.phenotypicGroup
(RPIP, UPIP only) Grouping indicating general association with normal flora, colonization, or contamination from the environment or other sources, as well as general association with disease
.associatedAmrMarkers
(Bacteria only) Information about the bacterial AMR markers associated with the microorganism
.associatedAmrMarkers.applicable
Boolean indicating whether one or more bacterial AMR markers are associated with the microorganism
.associatedAmrMarkers.detected
List of detected bacterial AMR markers associated with the microorganism
.associatedAmrMarkers.predicted
List of predicted bacterial AMR markers associated with the microorganism
.consensusGenomeSequences
(RPIP, RVOP/RVEK, VSP, VSP V2 viruses only) Information about the majority consensus genome (or segment) sequence
.consensusGenomeSequences.sequence
Consensus genome (or segment) sequence bases
.consensusGenomeSequences.referenceAccession
Accession of the reference genome (or segment) sequence
.consensusGenomeSequences.referenceDescription
Description of the reference genome (or segment) sequence
.consensusGenomeSequences.referenceLength
Length of the reference genome (or segment) sequence
.consensusGenomeSequences.maximumAlignmentLength
Longest contiguous alignment between consensus sequence and reference genome (or segment) sequence
.consensusGenomeSequences.maximumGapLength
Longest contiguous alignment gap (insertion or deletion) between consensus sequence and reference genome (or segment) sequence
.consensusGenomeSequences.maximumUnalignedLength
Longest section of the reference genome (or segment) sequence not aligned to by consensus sequence
.consensusGenomeSequences.coverage
Proportion of reference genome (or segment) sequence bases that appear in sample sequencing reads
.consensusGenomeSequences.ani
Average nucleotide identity of consensus sequence to reference genome (or segment) sequence
.consensusGenomeSequences.alignedReadCount
Number of sample sequencing reads that aligned to reference genome (or segment) sequence
.consensusGenomeSequences.medianDepth
Median depth of sample sequencing reads aligned to reference genome (or segment) sequence, indicating the median number of times each reference genome (or segment) sequence base appears in sample sequencing reads
.consensusGenomeSequences.targetAnnotation
List of targeted region annotations for the reference genome (or segment) sequence. Each annotation is a JSON object with the following fields: start (int), end (int), strand (string: "+", "-"), target_name (string), type (string)
.consensusGenomeSequences.condensedDepthVector
Read depth across the reference genome (or segment) sequence, condensed to 256 bins
.consensusTargetSequences
(RPIP viruses only) Information about the majority targeted region consensus sequences
.consensusTargetSequences.sequence
Consensus targeted region sequence bases
.consensusTargetSequences.name
Name of the targeted region
.consensusTargetSequences.referenceAccession
Accession of the targeted region reference sequence
.consensusTargetSequences.depthVector
Read depth across the targeted region reference sequence, not condensed
.consensusTargetSequences.scaledDepthVector*
Read depth across the targeted region reference sequence, condensed and scaled such that the longest targeted region for the microorganism has a maximum length of 256 bins
.predictionInformation
Information about microorganism prediction results
.predictionInformation.predictedPresent
Boolean indicating whether the microorganism passed its reporting logic algorithm
.predictionInformation.notes
List of notes about the prediction result
.predictionInformation.subpanels
List of pre-defined subpanels that the microorganism belongs to
.predictionInformation.relatedMicroorganisms
Array of objects with information about genetically related microorganisms. See below for details
.predictionInformation.userDefined*
User-defined reporting prediction logic for microorganism, if specified
.variants
(all RVOP/RVEK, VSP, and VSP V2 viruses, RPIP: SARS-CoV-2 & FluA/B/C only) Information about viral variants. See below for details
.comments*
List of additional information regarding the microorganism
.abundance*
Relative abundance of the microorganism within the microorganism class
.pangoLineage*
(SARS-CoV-2 only) Information about SARS-CoV-2 Pango lineage prediction results. See below for details
.nextclade*
(applicable viruses only) Information about viral clade assignment results. See below for details
.potentialAmrDetected*
(Bacteria only) Potential AMR detection flag for microorganism. Can be "Yes", “Not Detected”, or “n/a”
.potentialAmrPredicted*
(Bacteria only) Potential AMR prediction flag for microorganism. Can be "Yes", “Not Predicted”, or “n/a”
.flags*
(Bacteria only) Flag for potential resistance to an important drug class ("Potential ESBL", "Potential Carbapenemase")
.intrinsicResistance*
(Bacteria only) List of antimicrobials to which the reported bacteria is intrinsically resistant, based on CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100 34th Edition, Appendix B
.intrinsicResistanceDrugClasses*
(Bacteria only) List of drug classes to which the reported bacteria is intrinsically resistant, based on CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100 34th Edition, Appendix B
.name
Name of related microorganism
.onPanel
Boolean indicating whether the related microorganism is a panel member
.kmerReadCount
(UPIP only) Number of sample sequencing reads classified to related microorganism reference sequences
.coverage
Proportion of related microorganism reference sequence bases that appear in sample sequencing reads
.ani
Average nucleotide identity of consensus sequence to related microorganism reference sequences
.alignedReadCount
Number of sample sequencing reads that aligned to related microorganism reference sequences
.referenceAccession
Accession of reference genome (or segment) sequence used for variant calling
.segment
(Segmented viruses only) Segment number of reference segment sequence
.ntChange
Nucleotide change associated with variant
.referencePosition
Variant position in viral reference genome (or segment) sequence
.referenceAllele
Reference allele at variant position
.variantAllele
Variant allele
.depth
Variant depth, indicating the number of times variant position appears in sample sequencing reads
.alleleFrequency
Frequency of variant allele in sample sequencing reads
.category*
Variant category ("Viral Variant; Known AMR", "Viral Variant")
.comments*
List of additional information regarding the variant
.gene*
(SARS-CoV-2, Flu A/B/C only) Gene name
.product*
Protein product of gene
.annotation*
Type of change (e.g., "Nonsynonymous Variant")
.aachange*
Amino acid change associated with variant
.epistaticGroups*
List of epistatic groups variant is associated with
.standardNomenclatureEpistaticGroups*
(Flu A/B only) List of epistatic groups variant is associated with using standard nomenclature coordinates
.standardNomenclatureAaChange*
(Flu A/B only) Amino acid change associated with variant using standard nomenclature coordinates
.standardNomenclatureAccession*
(Flu A/B only) NCBI accession of the reference sequence used to establish standard nomenclature coordinates
.drugClasses*
List of drug classes variant is predicted to confer resistance to
.representativeAntimicrobials*
List of representative antimicrobials variant is predicted to confer resistance to
.inhibitionLevel*
(Flu A/B only) Level of inhibition per cited publications (see pmids)
.pmids*
PubMed IDs of publications associated with variant
Field
Description [Source]
.lineage*
From Pangolin: "The most likely lineage assigned to a given sequence based on the inference engine used and the SARS-CoV-2 diversity designated. This assignment may be sensitive to missing data at key sites"
.conflict*
From Pangolin: "In the pangoLEARN model, a given sequence gets assigned to the most likely category based on known diversity. If a sequence can fit into more than one category, the conflict score will be greater than 0 and reflect the number of categories the sequence could fit into. If the conflict score is 0, this means that within the current decision tree there is only one category that the sequence could be assigned to"
.ambiguityScore*
From Pangolin: "This score is a function of the quantity of missing data in a sequence. It represents the proportion of relevant sites in a sequnece which were imputed to the reference values. A score of 1 indicates that no sites were imputed, while a score of 0 indicates that more sites were imputed than were not imputed. This score only includes sites which are used by the decision tree to classify a sequence"
.version*
Version of the PUSHER database
.pangolinVersion*
Version of the Pangolin software
Field
Description [Source]
.sequenceName*
Name of the sequence
.referenceAccession*
Reference accession
.overallStatus*
Overall quality control status
.clade*
Assigned clade
.pangoLineage*
Pango lineage assigned by Nextclade
.cladeWho*
World Health Organization (WHO) nomenclature
.substitutions*
Total number of detected nucleotide substitutions
.totalNonACGTNs*
Total number of detected ambiguous nucleotides (nucleotide characters that are not A, C, G, T, N)
.totalMissing*
Total number of detected missing nucleotides (nucleotide character N)
.coverage*
Proportion of consensus genome (or segment) sequence bases that aligned to reference accession
.totalInsertions*
Total number of inserted nucleotide bases
.totalFrameShifts*
Total number of detected frame shifts
.stopCodons*
Total number of detected stop codons
.version*
Version of the Nextclade software
.class
Microorganism class ("bacterial")
.cardModelType
Bacterial AMR marker model type in the Comprehensive Antibiotic Resistance Database (CARD) ("homolog", "protein variant", "rRNA variant")
.cardGeneFamily
Bacterial AMR marker gene family in the Comprehensive Antibiotic Resistance Database (CARD)
.name
Bacterial AMR marker name
.cardName
Bacterial AMR marker name in the Comprehensive Antibiotic Resistance Database (CARD)
.ncbiName
Bacterial AMR marker name in the National Center for Biotechnology Information (NCBI) Reference Gene Catalog
.referenceAccession
Accession of the bacterial AMR marker reference sequence
.coverage
Proportion of bacterial AMR marker reference sequence residues that appear in sample sequencing reads (protein alignment for "homolog" and "protein variant" model types; nucleotide alignment for "rRNA variant" model type)
.pid
Percent identity of consensus sequence aligned to bacterial AMR marker reference sequence (protein alignment for "homolog" and "protein variant" model types; nucleotide alignment for "rRNA variant" model type)
.medianDepth
Median depth of sample sequencing reads aligned to bacterial AMR marker reference sequence, indicating the median number of times each bacterial AMR marker sequence residue appears in sample sequencing reads (protein alignment for "homolog" and "protein variant" model types; nucleotide alignment for "rRNA variant" model type)
.rpkm
Normalized representation of the number of sample sequencing reads aligned to bacterial AMR reference sequence (protein alignment for "homolog" and "protein variant" model types; nucleotide alignment for "rRNA variant" model type)
.alignedReadCount
Number of sample sequencing reads that aligned to bacterial AMR reference sequence (protein alignment for "homolog" and "protein variant" model types; nucleotide alignment for "rRNA variant" model type)
.nucleotideConsensusSequence
Nucleotide consensus sequence bases
.proteinConsensusSequence
Protein consensus sequence bases
.nucleotideDepthVector
Read depth across the bacterial AMR marker nucleotide reference sequence, not condensed
.proteinDepthVector
Read depth across the bacterial AMR marker protein reference sequence, not condensed
.associatedMicroorganisms
Information about the microorganisms associated with the bacterial AMR marker
.associatedMicroorganisms.all
List of all microorganisms associated with the bacterial AMR marker
.associatedMicroorganisms.detected
List of detected microorganisms associated with the bacterial AMR marker
.associatedMicroorganisms.predicted
List of predicted microorganisms associated with the bacterial AMR marker
.predictionInformation
Information about bacterial AMR marker prediction results
.predictionInformation.predictedPresent
Boolean indicating whether the bacterial AMR marker passed its reporting logic algorithm
.predictionInformation.confidence
Confidence level of bacterial AMR marker prediction ("high", "medium", "low")
.predictionInformation.notes
List of notes about the prediction result
.flags*
Flag indicating AMR marker is an extended-spectrum beta-lactamase (ESBL) or carbapenemase (Carbapenemase)
.representativeAntimicrobials*
List of representative antimicrobials the AMR marker is predicted to confer resistance to
.drugClasses*
List of drug classes the AMR marker is predicted to confer resistance to
.category
Variant category ("Bacterial Variant; Known AMR")
.referenceSourceMicroorganism
Microorganism that reference sequence is associated with in NCBI
.comments
List of additional information regarding the variant
.product
Protein product of gene
.ntChange
Nucleotide change associated with variant
.referencePosition
Variant position in reference sequence
.referenceAllele
Reference allele at variant position
.variantAllele
Variant allele
.depth
Variant depth, indicating the number of times variant position appears in sample sequencing reads
.alleleFrequency
Frequency of variant allele in sample sequencing reads
.annotation
Type of change (e.g. "Nonsynonymous Variant")
.aaChange
Amino acid change associated with variant
.epistaticGroups
List of epistatic groups variant is associated with
.representativeAntimicrobials*
List of representative antimicrobials variant is predicted to confer resistance to
.drugClasses*
List of drug classes variant is predicted to confer resistance to
.confidenceLevel*
(MTB only) Confidence level is given for Mycobacterium tuberculosis variants if provided by the WHO Catalogue of mutations in Mycobacterium tuberculosis (Final Grading Confidence; for rpoB only), or the Comprehensive Antibiotic Resistance Database (CARD), as part of a confidence model for AMR developed by the Relational Sequencing Tuberculosis Data Platform (ReSeqTB)
.pmids*
PubMed IDs of publications associated with variant
.name
Provided name of custom reference sequence, accession, genome, or microorganism
.coverage
Proportion of custom reference sequence bases that appear in sample sequencing reads
.ani
Average nucleolotide identity of consensus sequence to custom reference sequence or, if specified, collection of one or more custom reference sequences
.medianDepth
Median depth of sample sequencing reads aligned to custom reference sequence or, if specified, collection of one or more custom reference sequences, indicating the med\ian number of times each custom reference sequence base appears in sample sequencing reads
.condensedDepthVector
Read depth across custom reference sequence or, if specified, collection of one or more custom reference sequences, condensed to 256 bins
.rpkm
Normalized number of sample sequencing reads aligned to custom reference sequence or, if specified, collection of one or more custom reference sequences (targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads)
.alignedReadCount
Number of sample sequencing reads that aligned to custom reference sequence or, if specified, collection of one or more custom reference sequences
.consensusSequences
Array of objects with information about each consensus sequence. See below for details
.variants
Array of objects with information about variants detected in custom reference sequence or, if specified, collection of one or more custom reference sequences. See below for details
.pangoLineage*
Array of objects with information about SARS-CoV-2 Pango lineage prediction results. See below for details
.sequence
Majority consensus sequence bases
.referenceAccession
Accession of custom reference sequence
.referenceDescription
Description of custom reference sequence
.referenceLength
Length of custom reference sequence
.coverage
Proportion of custom reference sequence bases that appear in sample sequencing reads
.ani
Average nucleolotide identity of consensus sequence to custom reference sequence
.medianDepth
Median depth of sample sequencing reads aligned to custom reference sequence, indicating the median number of times each custom reference sequence base appears in sample sequencing reads
.depthVector
Read depth across custom reference sequence, not condensed
.alignedReadCount
Number of sample sequencing reads that aligned to custom reference sequence
.maximumAlignmentLength
Longest contiguous alignment between consensus sequence and custom reference sequence
.maximumGapLength
Longest contiguous alignment gap (insertion or deletion) between consensus sequence and custom reference sequence
.maximumUnalignedLength
Longest section of custom reference sequence not aligned to by consensus sequence
.ntChange
Nucleotide change associated with variant
.referenceAccession
Accession of custom reference sequence used for variant calling
.referencePosition
Variant position in custom reference sequence
.referenceAllele
Reference allele at variant position
.variantAllele
Variant allele
.depth
Variant depth, indicating the number of times variant position appears in sample sequencing reads
.alleleFrequency
Frequency of variant allele in sample sequencing reads
Field
Description [Source]
.lineage*
The most likely lineage assigned to a given sequence based on the inference engine used and the SARS-CoV-2 diversity designated. This assignment may be is sensitive to missing data at key sites
.conflict*
In the pangoLEARN model, a given sequence gets assigned to the most likely category based on known diversity. If a sequence can fit into more than one category, the conflict score will be greater than 0 and reflect the number of categories the sequence could fit into. If the conflict score is 0, this means that within the current decision tree there is only one category that the sequence could be assigned to
.ambiguityScore*
This score is a function of the quantity of missing data in a sequence. It represents the proportion of relevant sites in a sequnece which were imputed to the reference values. A score of 1 indicates that no sites were imputed, while a score of 0 indicates that more sites were imputed than were not imputed. This score only includes sites which are used by the decision tree to classify a sequence
.version*
Version of the PUSHER database
.pangolinVersion*
Version of the Pangolin software
.abbreviations*
Information about abbreviations relevant to test
.abbreviations.abbreviation*
Abbreviation
.abbreviations.definition*
Abbreviation definition
.interpretiveData*
Information about test
.interpretiveData.header*
Test information category
.interpretiveData.paragraph*
Test information text
AMR | antimicrobial resistance |
mL | milliliter |
NAI | neuraminidase inhibitor |
NGS | next-generation sequencing |
PAI | polymerase acidic endonuclease inhibitor |
pangolin | phylogenetic assignment of named global outbreak lineages |
RPKM | targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads |
RVEK | Respiratory Virus Enrichment Kit |
RVOP | Respiratory Virus Oligo Panel |
RUO | For Research Use Only. Not for use in diagnostic procedures. |
URL | See https://www.illumina.com/ for additional information. |
Quantification | RVOP data analysis using DRAGEN Microbial Enrichment Plus detects 24 viruses and 238 AMR markers based on target enriched next-generation sequencing (NGS) of viral DNA and cDNA sequences. Sequencing data are interpreted by the DRAGEN software platform and viruses that pass detection thresholds are reported. Relative abundance is expressed as proportion of RPKM values. |
AMR | This test detects 238 antimicrobial resistance (AMR) markers associated with resistance to Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) in Influenza A virus (H1N1pdm09), Influenza A virus (H1N1), Influenza A virus (H5N1), Influenza A virus (H3N2), Influenza A virus (H3N2; swine-like), Influenza A virus (H7N9), and Influenza B virus. AMR markers and drug associations are based on the World Health Organization (WHO) Influenza virus NAI and PAI Reduced Susceptibility Marker Tables (07 March 2023 version). Detection of an AMR marker is reported if the marker passes a minimum detection threshold and if the Influenza virus associated with the marker is also detected. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR variants does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information. |
AMR | Mutations connected with a '+' form an epistatic group. Epistatic groups are two or more mutations that need to be present concurrently to confer the associated resistance. |
Pango lineage | The most likely Pango (phylogenetic assignment of named global outbreak) lineage is assigned to the majority consensus SARS-CoV-2 genome sequence using pangolin 4.3.1 (Áine O'Toole & Emily Scher et al. 2021 Virus Evolution DOI:10.1093/ve/veab064). |
Limitations | Non-detected results do not rule out the presence of viruses and AMR markers. Contamination is possible during specimen collection, transport, and processing. Closely related viruses may be misidentified based on sequence homology to viruses present in the database. The identification of cDNA or DNA sequences from a virus does not confirm that the identified virus is causing symptoms, is viable, or is infectious. Recombinant viral strains may not be reported or may be reported as one or more individual viruses. Should one or more individual viruses be reported for a recombinant viral strain, antiviral resistance results may be inaccurate. In viral strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel. |
Limitations | Information provided by DRAGEN Microbial Enrichment Plus is based on scientific knowledge and has been curated; however, scientific knowledge evolves and reported information may not always be complete and/or correct. Results should be interpreted in the context of all available information. Other sources of data may be required for confirmation. |
NGS | next-generation sequencing |
pangolin | phylogenetic assignment of named global outbreak lineages |
RUO | For Research Use Only. Not for use in diagnostic procedures. |
URL | See https://www.illumina.com/ for additional information. |
Pango lineage | The most likely Pango (phylogenetic assignment of named global outbreak) lineage is assigned to the majority consensus SARS-CoV-2 genome sequence using pangolin 4.3.1 (Áine O'Toole & Emily Scher et al. 2021 Virus Evolution DOI:10.1093/ve/veab064). |
Limitations | Custom panel data analysis using DRAGEN Microbial Enrichment Plus aligns human-dehosted next-generation sequencing (NGS) reads to reference sequences. Contamination with microorganisms is possible during specimen collection, transport, and processing. Reads from closely related microorganisms may align to reference sequences based on sequence homology. Alignment of reads to a microorganism does not confirm that the microorganism is causing symptoms, is viable, or is infectious. Results should be interpreted in the context of all available information. Other sources of data may be required for confirmation. |
AMR | antimicrobial resistance |
mL | milliliter |
NAI | neuraminidase inhibitor |
NGS | next-generation sequencing |
PAI | polymerase acidic endonuclease inhibitor |
pangolin | phylogenetic assignment of named global outbreak lineages |
RPKM | targeted Reads mapped Per Kilobase of targeted sequence per Million quality-filtered reads |
VSP | Viral Surveillance Panel |
RUO | For Research Use Only. Not for use in diagnostic procedures. |
URL | See https://www.illumina.com/ for additional information. |
Quantification - when a quantitative Internal Control {ic_name} and concentration {ic_concentration} is specified | VSP (generation 2) data analysis using DRAGEN Microbial Enrichment Plus detects 200 viruses and 238 AMR markers based on target enriched next-generation sequencing (NGS) of viral DNA and cDNA sequences. Sequencing data are interpreted by the DRAGEN software platform and viruses that pass detection thresholds are reported. Absolute quantification assumes use of {ic_name} as an Internal Control spiked at {ic_concentration} copies/mL of sample. Relative abundance is calculated based on absolute quantities and is expressed as proportion of absolute quantities. If RPKM for the Internal Control is zero, no absolute quantification is provided, and relative abundance is expressed as proportion of RPKM values. |
Quantification - when a quantitative Internal Control is NOT specified | VSP (generation 2) data analysis using DRAGEN Microbial Enrichment Plus detects 200 viruses and 238 AMR markers based on target enriched next-generation sequencing (NGS) of viral DNA and cDNA sequences. Sequencing data are interpreted by the DRAGEN software platform and viruses that pass detection thresholds are reported. Relative abundance is expressed as proportion of RPKM values. Internal Control not specified; no absolute quantification provided. |
AMR | This test detects 238 antimicrobial resistance (AMR) markers associated with resistance to Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) in Influenza A virus (H1N1pdm09), Influenza A virus (H1N1), Influenza A virus (H5N1), Influenza A virus (H3N2), Influenza A virus (H3N2; swine-like), Influenza A virus (H7N9), and Influenza B virus. AMR markers and drug associations are based on the World Health Organization (WHO) Influenza virus NAI and PAI Reduced Susceptibility Marker Tables (07 March 2023 version). Detection of an AMR marker is reported if the marker passes a minimum detection threshold and if the Influenza virus associated with the marker is also detected. Reported AMR markers have been associated with antimicrobial resistance but may not always indicate phenotypic resistance. Failure to detect AMR variants does not always indicate phenotypic susceptibility. Results should be interpreted in the context of all available information. |
AMR | Mutations connected with a '+' form an epistatic group. Epistatic groups are two or more mutations that need to be present concurrently to confer the associated resistance. |
Read classification | This test differentiates sequencing reads classified to microorganism and Internal Control regions that are targeted by capture probes (“Targeted Microbial” and “Targeted Internal Control”) from those that are not targeted (“Untargeted”), are low complexity (“Low Complexity”), cannot be unambiguously assigned to one category (“Ambiguous”), or cannot be classified with confidence (“Unclassified”). |
Pango lineage | The most likely Pango (phylogenetic assignment of named global outbreak) lineage is assigned to the majority consensus SARS-CoV-2 genome sequence using pangolin 4.3.1 (Áine O'Toole & Emily Scher et al. 2021 Virus Evolution DOI:10.1093/ve/veab064). |
Limitations | Non-detected results do not rule out the presence of viruses and AMR markers. Contamination is possible during specimen collection, transport, and processing. Closely related viruses may be misidentified based on sequence homology to viruses present in the database. The identification of cDNA or DNA sequences from a virus does not confirm that the identified virus is causing symptoms, is viable, or is infectious. Recombinant viral strains may not be reported or may be reported as one or more individual viruses. Should one or more individual viruses be reported for a recombinant viral strain, antiviral resistance results may be inaccurate. In viral strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel. |
Limitations | Information provided by DRAGEN Microbial Enrichment Plus is based on scientific knowledge and has been curated; however, scientific knowledge evolves and reported information may not always be complete and/or correct. Results should be interpreted in the context of all available information. Other sources of data may be required for confirmation. |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | SARS-CoV-2 (relative to Wuhan-Hu-1/2019) | Official |
Influenza A virus (H1N1) | Influenza A H1N1pdm HA (relative to A/Wisconsin/588/2019) & Influenza A H1N1pdm NA (relative to A/Wisconsin/588/2019) | Official |
Influenza A virus (H3N2) | Influenza A H3N2 HA (relative to A/Darwin/6/2021) & Influenza A H3N2 NA (relative to A/Darwin/6/2021) | Official |
Influenza B virus (B/Victoria/2/87-like) | Influenza B Victoria HA (relative to B/Brisbane/60/2008) | Official |
Influenza B virus (B/Yamagata/16/88-like) | Influenza B Yamagata HA (relative to B/Wisconsin/01/2010) | Official |
Human respiratory syncytial virus A (HRSV-A) | RSV-A | Official |
Human respiratory syncytial virus B (HRSV-B) | RSV-B | Official |
Monkeypox virus (MPV) | Mpox virus (All Clades) | Official |
Measles virus (MV) | Measles virus N450 (WHO-2012) | Official |
Dengue virus (DENV), Dengue virus type 1 (DENV-1), Dengue virus type 2 (DENV-2), Dengue virus type 3 (DENV-3), Dengue virus type 4 (DENV-4) | Dengue virus (All Serotypes) | Official |
Human immunodeficiency virus 1 (HIV-1) | HIV-1 (relative to HXB2) | Community |
Influenza A virus (H5N1) | Influenza A H5Nx HA (relative to A/Goose/Guangdong/1/96) | Community |
Influenza A virus (H5N6) | Influenza A H5Nx HA (relative to A/Goose/Guangdong/1/96) | Community |
Influenza A virus (H5N8) | Influenza A H5Nx HA (relative to A/Goose/Guangdong/1/96) | Community |
Allobacillus halotolerans | X | X | X | X | X |
Armored RNA Quant Internal Process Control | X | X | X | X | X |
Enterobacteria phage T7 | X | X | X | X | X | X | Recommended IC concentration = 1.21 x 10^7 copies/mL of sample |
Escherichia virus MS2 | X | X | X | X | X | X |
Escherichia virus Qbeta | X | X | X | X | X |
Escherichia virus T4 | X | X | X | X | X | X |
Imtechella halotolerans | X | X | X | X | X |
Phocid alphaherpesvirus | X | X | X | X | X |
Phocine morbillivirus | X | X | X | X | X |
Truepera radiovictrix | X | X | X | X | X |
Read de-duplication | Not performed |
Depth threshold for consensus sequence generation | 1x |
Depth threshold for variant calling | 5x |
Minimum minor allele frequency | 20% |
Component versions
Test type, version:
RPIP 6.5.1
UPIP 8.6.0
RVOP 2.7.0
VSP 2.7.0
VSPv2 2.7.0
Custom 1.0.0
Analysis Pipeline version: 6.3.12
DRAGEN version: 4.3.11
Third-party versions
Pangolin 4.3.1 (Pangolin database PUSHER version 1.27)
Nextclade 3.5.0
SnpEff 5.1
ResFinder (version 2.2.1)
NCBI Reference Gene Catalog (version 2023-09-26.1)
EUCAST expert rules on indicator agents (2019-2023)
CLSI Performance Standards for Antimicrobial Susceptibility Testing (M100 34th Edition)
Comprehensive Antibiotic Research Database (CARD, version 3.2.8)
Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1)
World Health Organization (WHO) Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) Reduced Susceptibility Marker Tables (07 March 2023 version)
Key updates
Various bug fixes (see below)
Tiered reporting added for Norovirus (GI, GII, GIV, GVIII, GIX) and Dengue virus (type 1, type 2, type 3, type 4)
Tiered reporting suppressed for below subtype resolution of Influenza A virus subtypes H1N1 and H3N2
Nextclade datasets added for Measles virus (MV) and Dengue virus (DENV) clade assignment
Reference genomes added for Monkeypox virus (MPV) Clade 1b
Additional database curation
Known issues
Coverage results for SARS-CoV-2 are slightly (<1%) over-estimated, which may result in coverage >100% due to an error accounting for masked polyA-tail bases
When reading Biosamples from a Project, Fastq files for Biosamples sharing the same sample name prefix before the first underscore are merged. For example, Fastq files for Biosamples PREFIX_001 and PREFIX_002 will be merged and reported as a single PREFIX sample. To avoid this error, ensure that sample names are unique before the first underscore, replace underscores with a hyphen, or provide Biosample input from a list
Known limitations
When providing Biosample input from a list, 99 associated Fastq files is the maximum allowed per analysis. There is no Fastq file limitation when reading Biosamples from a Project
In strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel
Small differences in SARS-CoV-2 and Influenza virus results may be observed between repeat analyses
Bug fixes
Nextclade parsing errors for some samples
Custom reference sequence analysis not functional in non-US regions
User-defined microorganism reporting feature not reporting microorganisms that belong to a tiered reporting group when “prediction_logic” column set to “default”
RPKM and absolute quantity metrics inaccurate when read QC disabled
SHV beta-lactamase AMR markers incorrectly reported as carbapenemases based on a known curation error in CARD version 3.2.8
Reads duplicated for samples with a single FASTQ file
Empty FASTQ files abort analysis
Pangolin not run on all samples with SARS-CoV-2 detected
Viral genome coverage plots not rendered for segmented viruses when all segments not detected
Description information missing for some viral genome accessions
Initial release.
Component versions
Test type, version:
RPIP 6.3.0
UPIP 8.4.0
RVOP 2.3.0
VSP 2.3.0
VSPv2 2.3.0
Custom 1.0.0
Analysis Pipeline version: 6.3.12
DRAGEN version: 4.3.6
Third-party versions
Pangolin 4.3.1 (Pangolin data 1.27)
Nextclade 3.5.0
SnpEff 5.1
ResFinder (version 2.2.1)
NCBI Reference Gene Catalog (version 2023-09-26.1)
EUCAST expert rules on indicator agents (2019-2023)
CLSI Performance Standards for Antimicrobial Susceptibility Testing (M100 34th Edition)
Comprehensive Antibiotic Research Database (CARD, version 3.2.8)
Comprehensive Antibiotic Research Database Prevalence Data (CARD Prevalence, version 4.0.1)
World Health Organization (WHO) Influenza virus neuraminidase inhibitor (NAI) and polymerase acidic protein inhibitor (PAI) Reduced Susceptibility Marker Tables (07 March 2023 version)
Key updates
Updated and expanded microorganism and bacterial AMR marker databases
Updated and expanded Influenza virus typing capability and antiviral resistance (AVR) reporting
User-defined microorganism reporting list and reporting thresholds
Below threshold reporting for microorganisms and/or AMR markers
Custom reference sequence analysis
Known issues
Reads are duplicated for samples with a single FASTQ file
Empty FASTQ files will abort analysis
Nextclade may encounter a parsing error for some samples. If an analysis fails, try re-running the analysis with Nextclade disabled
Pangolin may not be run on all samples with SARS-COV-2 detected
Custom reference sequence analysis is not functional in non-US regions
The user-defined microorganism reporting feature does not report microorganisms that belong to a tiered reporting group when the “prediction_logic” column is set to “default”. See the User Guide for further information about microorganism tiered reporting
RPKM and absolute quantity metrics are inaccurate when read QC is disabled
SHV beta-lactamase AMR markers are incorrectly reported as carbapenemases based on a known curation error in CARD version 3.2.8
Coverage results for SARS-CoV-2 are slightly (<1%) over-estimated, which may result in coverage >100% due to an error accounting for masked polyA-tail bases
When reading Biosamples from a Project, Fastq files for Biosamples sharing the same sample name prefix before the first underscore are merged. For example, Fastq files for Biosamples PREFIX_001 and PREFIX_002 will be merged and reported as a single PREFIX sample. To avoid this error, ensure that sample names are unique before the first underscore, replace underscores with a hyphen, or provide Biosample input from a list
Known limitations
When providing Biosample input from a list, 99 associated Fastq files is the maximum allowed per analysis. There is no Fastq file limitation when reading Biosamples from a Project
Small differences in results may be observed between repeat analyses
In strains containing insertion-deletion mutations (indels), there is a risk of false positive or false negative results for other resistance mutations within a region of 100 nucleotides around the indel
The RPIP, VSPv2, VSPv1, and RVOP Data Analysis solutions can report Influenza A virus subtypes H1N1 and H3N2 to a below-subtype resolution. Multiple results for H1N1 and/or H3N2 may be reported concurrently, particularly in samples that contain a mixture of Influenza A virus subtypes
Viral genome coverage plots are not rendered for segmented viruses when all segments are not detected
Description information is missing for some viral genome accessions